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Abstract
What discharge properties are expressed by varying-sized sympathetic action potential (AP)
subpopulations active under baseline conditions in humans and what are the governing
mechanisms? To address this overall question the microneurographic approach was
employed to record multi-unit muscle sympathetic nerve activity (MSNA), after which a
continuous wavelet transform exposed APs in the recorded neurogram. Study One examined
the role of the paravertebral ganglia on sympathetic neural discharge patterns. Through
trimethaphan infusion under baseline conditions, this study revealed ordered de-recruitment
of larger to smaller AP clusters, suggesting that the paravertebral ganglia contribute to the
distribution of firing probabilities expressed by differently-sized sympathetic APs. However,
the smallest APs were resistant to trimethaphan, suggesting non-nicotinic mechanisms
contribute to ganglionic neurotransmission of this specific subpopulation of axons. Study
Two investigated the synchronization of APs within the cardiac cycle and the role played by
the paravertebral ganglia in this process. We observed that under baseline conditions ~30%
of total sympathetic APs fired asynchronously between bursts of MSNA and asynchronous
discharge frequency was not affected by baroreflex or apneic stress. Thus, asynchronous AP
discharge represents a fundamental behaviour within human MSNA. Also, retrospective
analysis of asynchronous AP data from Study One demonstrated that non-nicotinic
ganglionic mechanisms contributed to some, but not all asynchronous AP discharge. Study
Three probed the heterogeneity of baroreflex control over the discharge of AP
subpopulations. Under baseline conditions, we found a subpopulation of medium-sized APs
to express the greatest baroreflex gain, while the smallest and largest APs exhibited minimal
baroreflex regulation. During baroreflex stress imposed by lower body negative pressure, the
ii

sympathetic system increases total MSNA by resetting baroreflex control of medium APs to
higher levels of activity and increasing the gain to facilitate augmented firing along with
recruiting a subpopulation of previously silent larger APs. Overall, these studies provide new
knowledge regarding the complex discharge patterns expressed by subpopulations of
varying-sized sympathetic APs active at baseline, of which some express augmented firing
during baroreflex stress. We also provide insight to the baroreflex and ganglionic
mechanisms governing the discharge of these AP subpopulations.
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Summary for Lay Audience
For humans to survive, blood pressure must be maintained within an optimal range and
oxygenated blood flow must be delivered to vital organs such as the brain and the heart. Part
of the brain known as the sympathetic nervous system ensures these conditions by sending
precise messages along the nerves to communicate with the heart and blood vessels. These
messages are made up of electrical signals called action potentials. During periods of stress
that change our blood pressure and blood flow ¾ such as the fall in blood pressure that
occurs when we stand ¾ the brain changes the message sent to the heart and blood vessels
by adjusting the size, number, and timing of action potentials. This message tells the blood
vessels to constrict and the heart to beat faster, which increase blood pressure and ensures
blood flow to vital organs. This dissertation provided new information regarding the action
potential messages used by the sympathetic nervous system to communicate with the blood
vessels and identified parts of our nervous system that are important for shaping these
messages.
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Chapter 1

1

Introduction

Critical to homeostasis and human survival are the sympathetic messages coordinating
circulatory responses to physiological stress (106, 131). These efferent messages result
from the integration of feedback signals arising from peripheral receptors and
feedforward signals generated centrally into a network of supraspinal nuclei, with further
processing by spinal circuits and the paravertebral ganglia (28, 37, 42, 78). Pioneered by
Hagbarth and Vallbo in 1968 (49), microneurography provides direct access to the
discharge patterns of the population of postganglionic c-fibres innervating the vasculature
supplying skeletal muscle in humans ¾ muscle sympathetic nerve activity (MSNA). Due
to the low signal-to-noise ratio, early investigations relied on the integrated signal to
uncover the fundamental behaviours contained within MSNA: spontaneous bursts of
activity expressing time-varying frequency and amplitude (26, 49).
It was not until recent advances in recording techniques and signal processing that the
action potentials (AP) underlying the integrated bursts were revealed (81, 98). Among
low-threshold APs that are synchronized into bursts under baseline conditions, multiple
size-related subpopulations exist, expressing heterogeneous discharge probabilities:
medium APs fire within most bursts, while the small and large APs express low withinburst probabilities (110). While burst frequency stems from the quantity of baroreflexgated periods of synchronized AP discharge, burst size depends on the number and size
of synchronized APs (79, 101, 110). To increase total MSNA during physiological stress,
the sympathetic system increases the activity of low-threshold APs (79) and recruits a
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subpopulation of previously-silent larger and faster conducting APs (6). Thus, lowthreshold APs are essential for communicating circulatory adjustments necessary for
homeostatic maintenance during baseline conditions and physiological perturbations.
However, the discharge properties expressed by subpopulations of low-threshold APs
remain incompletely understood and the mechanisms contributing to both differential
firing among variously-sized APs under baseline conditions and the increase in emissions
during physiological stress remain unclear. Therefore, the overall objective of the
present dissertation was to investigate the behaviour and governing mechanisms of the
low-threshold (i.e., active at baseline) sympathetic AP subpopulations. This dissertation
tested the overall hypothesis that heterogeneous discharge behaviour exists among
varying-sized low-threshold AP subpopulations under baseline conditions and during
physiological stress, due to differing regulation within the sympathetic organization.
Specific hypotheses tested in this dissertation are as follows:
Study One
The role of the paravertebral ganglia in human sympathetic neural discharge patterns
Tested the hypothesis that the paravertebral ganglia contribute to the discharge
behaviours expressed by sympathetic APs active at baseline in humans.
Study Two
Asynchronous action potential discharge within human muscle sympathetic nerve activity
Tested the hypothesis that synchronous and asynchronous discharge exist among
sympathetic APs and the ganglia affect AP synchronicity.
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Study Three
Baroreflex control of sympathetic action potential subpopulations during orthostatic
stress
Tested the hypothesis that during orthostatic stress the baroreflex confers its greatest
effect on the gain of medium AP clusters that fire normally with high probability. If so,
then the change in position and slope of each AP cluster’s baroreflex curve should vary
across the distribution of recorded APs.
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1.1

Sympathetic Nervous System

The sympathetic nervous system, a division of the autonomic nervous system, maintains
homeostasis and supports survival by communicating integrative physiological responses
to both spontaneous and stress-imposed deviations in blood pressure and blood flow (17,
24). Key to homeostatic maintenance are rapid alterations in sympathetic discharge
destined for the heart and vasculature that enable modifications in cardiac output and
vascular resistance (104, 131). While anticipatory feedforward adjustments participate in
circulatory regulation, negative feedback circuits represent the critical element underlying
short-term sympathetic regulation and circulatory homeostasis (44). According to the
homeostat model (44), peripheral receptors initiate feedback reflexes as they ‘monitor’
the internal environment, relaying information centrally regarding blood pressure and
volume, the chemical environments of the blood and muscle, and lung stretch, among
other signals (37). A network of central nuclei establishes a ‘set-point’ for each
physiological variable, such that when sensory nerves communicate a deviation from this
level the system adjusts sympathetic outflow to modify effector organ function
appropriately to correct the error (44). As such, sympathetic messages directed towards
the circulation are goal-oriented and graded to the level of stress (106).
Even the earliest views of integrated physiology predicted that the neural organization of
complex organisms reflexively maintain vital properties of the internal environment or
milieu intérieur in response to the “colossal forces, often adverse”, surrounding the body
(17). As an example, while not apparently colossal, even the gravitational force
experienced during standing imposes a redistribution of 500 to 1,000 mL of venous blood
to the lower body, primarily in the abdominal cavity and buttocks, that if not
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compensated for results in loss of consciousness subsequent to compromised cardiac
output, hypotension, and reduced cerebral perfusion (107). However, in a healthy system,
reductions in the distension of baroreceptor harbouring vessels linked to falling blood
pressure withdraw baroreflex-mediated sympathoinhibition to increase sympathetic
outflow to the heart and vasculature (104). Along with the concurrent parasympathetic
response, enhanced sympathetic discharge elevates cardiac output by increasing heart rate
and myocardial contractile force (12). Simultaneously, elevated sympathetic drive
increases vascular resistance to augment blood pressure and venous return by limiting
peripheral blood flow (12). Nonetheless, the contemporary understanding of
neurocirculatory homeostasis appreciates rhythmic oscillations, in blood pressure for
example, produced by an interaction of feedback pathways, even in supine resting
conditions (63).
Alteration of sympathetic regulatory mechanisms produces chronically elevated
sympathetic outflow which relates to a host of cardiovascular pathologies. Sympathetic
outflow directed towards skeletal muscle vasculature (i.e., MSNA) increases with age
(116) and while no relationship exists between baseline MSNA and mean arterial
pressure in young individuals, these variables express a positive association from about
middle-age onwards (87). Accordingly, middle-aged and elderly patients with
hypertension commonly display elevated MSNA (46). Interestingly, younger individuals
diagnosed with essential hypertension also express high sympathetic activity (46)
suggesting deteriorations in the mechanisms buffering MSNA and blood pressure [e.g.,
inverse relationships between MSNA and cardiac output/vasoconstrictor responsiveness
(19, 20)] in normotensive counterparts. Also, consistently elevated MSNA associates
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with heart failure (73), coronary artery disease (4), obstructive sleep apnea (108), chronic
renal failure (47), and metabolic syndrome (56) among other conditions (46, 104). Thus,
despite being an integral component of homeostatic maintenance, deterioration of
sympathetic feedback pathways or allostatic modifications shifting the feedback reflex to
a new set-point, adversely affects overall health (43).

1.2

Sympathetic Neurocircuitry

The sympathetic neural messages ultimately communicating the appropriate circulatory
responses to physiological stress are a product of the central and peripheral organization
of the sympathetic nervous system (59). Because the arterial baroreflex has received the
bulk of research attention (12, 23), the impact of each nuclei comprising this pathway on
sympathetic discharge is established. However, many non-baroreflex processes (and
neural behaviours) also warrant discussion as they exist within the sympathetic
organization and shape sympathetic outflow (112). The following discourse provides a
non-exhaustive overview of the neural architecture of the sympathetic nervous system.

1.2.1

The Baroreflex

Baroreflex regulation of sympathetic and parasympathetic activity ensures maintenance
of blood pressure within an optimal narrow range. Two divisions of the baroreflex exist:
1) the arterial (or high-pressure) baroreflex, which relies on baroreceptors located in the
carotid sinuses and aortic arch to signal blood pressure changes to the brain; and 2) the
cardiopulmonary (or low-pressure) baroreflex, initiated by baroreceptors in the right
atrium and ventricle along with pulmonary vessels communicating blood volume and
cardiac filling pressures (32, 37). Dispersions in transmural pressure evoking tissue
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stretch alter the firing rate of mechanosensitive baroreceptors (58). Overall, the
baroreflex ensures negative-feedback such that increased transmural pressure within
baroreceptor-harbouring regions modulates sympathetic outflow and augments
parasympathetic discharge. These neural changes increase total peripheral resistance and
cardiac output sufficiently to maintain mean arterial pressure during orthostatic stress,
with alterations in resistance representing the primary mechanism (32). Briefly, the
fundamental baroreflex neurocircuitry in the brainstem relies on the nucleus tractus
solitarius (NTS) which in the pathway subserving parasympathetic regulation, NTS
neurons send excitatory projections (releasing glutamate) to the preganglionic
parasympathetic neurons in the nucleus ambiguus and the dorsal motor nucleus. In the
pathways subserving sympathetic regulation the NTS sends excitatory projections to
caudal ventrolateral medulla (CVLM) neurons, which in turn, send inhibitory signals
(releasing g-amino butyric acid; GABA) to pre-sympathetic neurons within the rostral
ventrolateral medulla (RVLM) (12, 109). This neural pathway has received the majority
of research attention and while it strongly shapes sympathetic discharge behaviour, it
does not represent the entirety of the central sympathetic circuitry (8, 23, 105).
The baroreflex primarily defends blood pressure during standing (and as reviewed
elsewhere (86, 95), during physical exercise), but in the laboratory orthostatic stress may
be imposed by Valsalva’s Manoeuvre, head-up tilt, pharmacological infusions (e.g.,
sodium nitroprusside), or lower body negative pressure (LBNP) (89). LBNP enables
investigators to titrate the degree of orthostatic stress, unload all baroreceptor
populations, and prevents participant movement, enabling simultaneous
microneurographic recordings under closed-loop conditions (89). Once investigators
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secure the participant’s lower body within an air-tight chamber, chamber decompression
to sub-atmospheric pressures induces a redistribution of blood from central regions (i.e.,
abdomen and thorax) to the venous system of the lower body (i.e., splanchnic circulation,
buttocks, thighs, and legs) (136). The magnitude of venous pooling scales to LBNP
magnitude. Mild LBNP (e.g., ≤ -20 mmHg) evokes venous pooling sufficient to reduce
central venous pressure and unload cardiopulmonary baroreceptors, with negligible
impact on stroke volume and cardiac output, leaving arterial baroreceptors unperturbed
(68). Interpretations of autonomic responses to mild LBNP should be made with caution
however, as Taylor and colleagues (122) observed reduced ascending aortic diameters
during -5 mmHg LBNP, suggesting aortic arch baroreceptor unloading even during
conditions where pressure is unchanged compared to baseline (70). LBNP greater than
approximately -20 mmHg reduces venous return sufficient to modulate stroke volume,
cardiac output and pulse pressure (due to reductions in systolic pressure); this stress
unloads both cardiopulmonary and arterial baroreceptor populations (68).
Cardiopulmonary baroreflex stress increases sympathetic discharge destined for the
periphery, whereas arterial baroreflex unloading increases sympathetic discharge directed
towards the heart and visceral vascular beds (1).

1.2.2

Non-Baroreflex Sympathetic Neurocircuitry

The collection of pre-sympathetic neurons within the RVLM are vital to the generation of
pre- and post-ganglionic discharge based on anatomical evidence of RVLM projections
to preganglionic neurons (112) and the consistent observation that destruction of RVLM
cells in anaesthetized felines results in a large drop in blood pressure (48). As outlined
above, RVLM neurons are integral to the baroreflex neurocircuitry and are strongly
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inhibited by the CVLM during baroreflex loading (12). This CVLM inhibitory feature is
reduced during baroreflex unloading accompanying orthostatic stress, enabling elevated
sympathetic outflow from the RVLM (12, 78). Thus, other neural mechanisms generate
the RVLM activity critical for preganglionic sympathetic discharge and ultimately the
postganglionic AP behaviour observed in microneurographic recordings.
Researchers have proposed two primary hypotheses to explain RVLM discharge. The
pacemaker theory suggests that intrinsic depolarization of some RVLM neurons drives
sympathetic outflow (25). Using both intracellular and extracellular recordings, Sun and
colleagues observed rhythmical pacemaker-like discharge of rat RVLM neurons under
conditions where excitatory neurotransmission had been pharmacologically reduced or in
the absence of excitatory postsynaptic potentials (EPSP) (114, 115). Alternatively, the
network theory holds that excitatory and inhibitory synapses arising from several groups
of neurons affects RVLM behaviour (23). In support of this concept, Lipski and
colleagues found no evidence of rhythmical membrane depolarization of rat RVLM
neurons preceding AP discharge, but rather observed EPSPs to drive spiking, indicating
excitatory synapsing (75). Indeed, anatomic and functional studies have revealed that the
RVLM participates in sympathoexcitatory reflexes (e.g., chemoreflex, metaboreflex) and
receives synaptic inputs from a host of neurons beyond the CVLM (many of which form
an interconnected network) including the NTS, periaqueductal gray, caudal vestibular
nucleus, lateral tegmental field, periventricular nucleus (PVN) and lateral nucleus of the
hypothalamus, the mesencephalic locomotor region, the amygdala, medial prefrontal
cortex, and insular cortex (8, 23, 128).
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The influence of some non-baroreflex sites on sympathetic discharge patterns have been
revealed by direct stimulation studies in animals and humans. For example, chemical
stimulation of the hypothalamic PVN in anaesthetized rats increased the amplitude but
not the frequency of integrated bursts of renal sympathetic nerve activity (83). This effect
may be mediated by synapses with the RVLM (8, 22, 138); however, axons arising from
some cells within PVN of the hypothalamus also bypass the medulla and synapse directly
with spinal sympathetic preganglionic neurons at multiple levels (e.g., preganglionic
nerves ultimately supplying the heart and adrenal gland) (11, 23, 61). Similarly, electrical
stimulation of the dorsolateral periaqueductal gray via implanted electrodes in humans
increased the proportion of larger bursts of integrated MSNA compared to baseline
conditions, but did not affect burst frequency (119). Interestingly, in addition to
synapsing with the RVLM, periaqueductal gray neurons are also reciprocally connected
the hypothalamus (11), suggesting that the effect seen in humans may have occurred
through hypothalamic activation. As discussed below, changes in MSNA burst frequency
can be explained by arterial baroreflex regulation while factors affecting burst size — a
function of the number and size of synchronously firing APs — remain to be elucidated
fully (66, 110, 117).

1.2.3

Sympathetic Preganglionic Neurons

The cell bodies of sympathetic preganglionic neurons reside in the spinal cord, forming
clusters primarily located in the intermediolateral cell column, but also in the central
autonomic area lying dorsolateral to the central canal, in the intercalated nucleus between
the intermediolateral cell column and the central autonomic area, and in the white matter
of the dorsolateral funiculus (76, 113). Preganglionic neurons possess dendritic
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arborizations broad enough to facilitate connections between neuronal clusters on
ipsilateral and contralateral sides of the spinal midline (27, 127), which may contribute to
synchronicity among postganglionic APs in each nerve (110) as well as bursting
coherence in bilateral limb recordings (30). Also, cell bodies and dendrites of
neighbouring preganglionic neurons form electrical synapses known as gap junctions
which enable electrically-coupled networks and synchronous firing (28). Large dendritic
fields accept both excitatory and inhibitory synapses from supraspinal nuclei which
primarily generate their activity, along with sensory inputs emerging from the muscle and
skin (23, 76). Importantly, preganglionic activity results from a complex spinal network
formed by interneurons receiving input from all sensory nerves and some supraspinal
regions (28).
In addition to classic neurotransmitters (e.g., glutamate) synaptic inputs release a variety
of peptides [e.g., neuropeptide Y (NPY), substance P, angiotensin II, oxytocin] and
catecholamines [e.g., norepinephrine (NE)] that may affect preganglionic excitability (23,
28). Indeed, some feline intermediolateral preganglionic neurons exposed to NE
expressed rhythmic oscillations in membrane potential independent of synaptic input
suggesting the potential for conditional pacemaker activity (137). Several other studies
support the idea that preganglionic neurons or a spinal network contributes to
sympathetic discharge recorded from postganglionic nerves. For example, in spinally
transected (cervical level) rats, lumbar sympathetic discharge at the 2-6 Hz rhythm was
restored following application of an excitatory amino acid, suggesting that supraspinal
inputs are necessary for generating sympathetic outflow but some discharge
characteristics are generated by preganglionic networks (2). Preganglionic neurons are
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myelinated and emerge from the ventral spinal cord via the white ramus (132) and while
most project to the ganglion at the same spinal level, others project either rostrally or
caudally to synapse at nearby ganglia (113).

1.2.4

The Paravertebral Ganglia

The paravertebral ganglia describe the neural chains running parallel to the vertebrae
where c-fibre cell bodies are organized into clusters and receive synaptic input from
preganglionic nerves projecting from the spine (84). Through patterns of divergent and
convergent synaptic organization the ganglia ensure that central sympathetic messages
are faithfully distributed to peripheral targets but may also be integrated and modified
accordingly (42). The ganglia amplify the distribution of the centrally arising message
through divergent connections, which describes the synaptic phenomenon where each
preganglionic neuron synapses with multiple postganglionic neurons (41, 59). While the
pattern of divergence varies between ganglia and the volume of target tissue, estimates
suggest that one preganglionic neuron synapses with a pool of about 100 postganglionic
neurons in humans (31). Theoretically, divergence may contribute to synchronized
discharge among postganglionic nerves as multiple c-fibres can be depolarized by the
same input signal. Also, the recruitment of one previously-silent preganglionic neuron
may represent a simple strategy for increasing the number of synchronously firing
postganglionic nerves.
Convergence defines the pre-to-postganglionic nerve organization where each
postganglionic neuron receives inputs from multiple preganglionic axons (84). This
feature enables the ganglia to serve as an additional juncture for integration rather than
strictly relaying information. Each postganglionic cell body receives between 2 and 15
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preganglionic inputs (94). However, among preganglionic inputs to a single
postganglionic nerve, the strength or ability to evoke postganglionic discharge varies and
may be classified as primary (strong) or accessory (weak) inputs (59). While earlier
studies indicated that postganglionic firing resulted only from the activity of primary
inputs, recent studies including those performed in vivo in mammals have revealed that
integration of convergent accessory inputs augments the firing rate of the postganglionic
nerve beyond that evoked invariably by the primary input (13, 65, 96). For example,
evidence suggests that postganglionic APs may be evoked by a pair of accessory inputs
firing near simultaneously or a single accessory input firing twice in rapid succession (55,
65). Intriguingly, there also exists a subpopulation of accessory inputs whose strength
fluctuates over time but often generates sufficient depolarization to drive postganglionic
firing (13, 96). Synaptic convergence may contribute to the complexity of sympathetic cfibre discharge as the number of preganglionic synapses scales with dendritic surface
area, which relates to neuronal size (41). Therefore, larger neurons are expected to
receive a greater number of preganglionic synapses (excitatory and inhibitory),
potentially from different subpopulations of spinal nerves.
Pre-to-postganglionic transmission occurs mainly via cholinergic mechanisms at the
ganglia. AP arrival at the preganglionic axon terminals initiates an intracellular cascade
resulting in acetylcholine (ACh) release into the synaptic cleft (45). ACh molecules
surviving breakdown by acetylcholinesterase in the cleft may bind to nicotinic receptors
located on the dendritic and somatic surfaces of the postganglionic neuron (NN nicotinic
receptors) (129). These nicotinic receptors are ligand-gated ion channels that undergo
conformational changes upon ACh binding, enabling channel opening and sodium (Na+)
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influx (45). Depolarization of the cell body, known as a postsynaptic potential, is
responsible for generating an AP but only if this depolarization or the sum of the
postsynaptic potentials reaches the threshold for AP initiation (~ -50 mV) (92).
Postsynaptic potentials arising from cation influx are known as EPSPs but inhibitory
postsynaptic potentials also exist, reducing the likelihood of AP generation (92). While
nicotinic receptors represent the primary mechanism for postganglionic firing, ACh may
also bind muscarinic receptors which are expressed on some postganglionic neurons (59,
129). Unlike nicotinic mechanisms, muscarinic receptor binding by ACh results in a
slower EPSP due to the G-protein coupled structure and required intracellular signaling
cascade to initiate postsynaptic potentials (132).
The paravertebral ganglia also exist as a site for non-cholinergic neurotransmission.
Many preganglionic neurons contain chemical co-transmitters that are released with ACh
and postganglionic synaptic targets expressing the appropriate receptor. According to the
neurochemical coding hypothesis (41, 84), co-transmitter release varies by neuron and
links to the functional sub-type of pre-and-postganglionic nerves (39). Many cotransmitters have now been identified including (but not limited to): adenosine, adenosine
tri-phosphate (ATP), dopamine, GABA, nitric oxide, NPY, and substance P (28, 132).
Co-transmitter release represents a further option for postganglionic activation or
inhibition; however, in many cases this appears to occur through slow postsynaptic
potentials which affect postganglionic activity directly along with facilitating or
modulating depolarization by fast EPSPs (52, 84, 129). Also, due to their position outside
the blood-brain barrier (132), the ganglia are exposed to a variety of circulating
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substances (e.g., angiotensin II) that may affect neurotransmitter release or
postganglionic excitability in a similar manner (18, 38).

1.2.4.1

Postganglionic Nicotinic Blockade: Trimethaphan

In humans and lower animals, ganglionic neurotransmission via nicotinic mechanisms
can be abolished through pharmacological intervention. Trimethaphan camsylate
(Arfornad) is a selective nondepolarizing competitive antagonist of postganglionic
nicotinic receptors (97). The onset of nicotinic blockade occurs within 1 to 5 minutes and
lasts about 10 minutes (26, 126). Administration occurs by intravenous infusion with
doses starting at 0.5 – 1 mg/min. Clinically, trimethaphan was used for blood pressure
management during surgery but was discontinued and now the remaining supply exists
for physiological research (135). Nicotinic ganglionic blockade may be verified by
negligible (< 5 bpm) heart rate responses to Valsava’s Manoeuvre or by the absence of
integrated MSNA bursts in microneurographic studies (7, 9). Importantly, nicotinic
blockade via trimethaphan infusion revealed the efferent nature of MSNA (26) and
insight to sympathetic circulatory control in humans (21, 62).

1.2.5

Sympathetic Postganglionic Neurons

Sympathetic postganglionic neurons exit the paravertebral ganglia via the gray ramus,
projecting towards cardiovascular end-targets. Microneurographic recordings for the
studies comprising this dissertation were made from the peroneal (also called the fibular)
nerve, a branch of the sciatic nerve arising from the lumbosacral plexus (4th lumbar
segment to 3rd sacral segment) (123). Tyrosine-hydroxylase (i.e., enzyme for
catecholamine synthesis) stained postganglionic axons obtained from the peroneal nerve
of human cadavers revealed that these nerves do not form their own fascicles but are
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organized in bundles among myelinated nerves ranging in number from 1 to about 45
axons (median: 5 axons) (124). Sympathetic c-fibres range in size from 0.5 to 2 µm
(124), supporting the observation of varying-sized APs (confirmed by conduction
velocities) within human multi-unit recordings (106). This dissertation focuses on the
postganglionic axons within the peroneal nerve that are directed to vascular smooth
muscle supplying skeletal muscle. Postganglionc c-fibres traverse arteries as they branch,
forming a plexus within the adventitia and interface the smooth muscle via bulging
varicosities containing synaptic vesicles then continue on and form varicosities distally
(133). This organization, referred to as synapse en passant, enables a single
postganglionic nerve to innervate a large volume of the vasculature (132). Size variability
among postganglionic c-fibres may confer graded vasoconstrictor control as larger
neurons innervate a larger vascular field in guinea pigs (40).
Fundamentally, AP arrival at the varicosity depolarizes the cellular membrane opening
voltage-gated calcium channels to initiate calcium influx, which causes vesicular
exocytosis and neurotransmitter release (132). Briefly, the primary neurotransmitters
released by sympathetic nerve varicosities are NE, NPY, and ATP (133). The major
source of vasoconstriction for NE results from binding postsynaptic alpha-1 (a1R) and
alpha-2 (a2R) adrenergic receptors on the smooth muscle (104). For NPY and ATP, the
receptors primarily mediating vasoconstriction are the NPY Y1R and P2X1 receptors,
respectively (104). a1R activation results in calcium release from the sarcoplasmic
reticulum via Gq-protein related phospholipase C production, subsequent inositol 1,4,5trisphosphate (IP3) production and sarcoplasmic IP3 receptor binding (90).
Neurotransmitter binding of NPY Y1R and a2R inhibit cyclic adenosine monophosphate
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(cAMP) production via Gi-protein related attenuation of adenylyl cyclase activity (133).
A reduction in cAMP activates myosin light chain kinase which phosphorylates myosin
light chain to cause vasoconstriction. Last, P2X1 receptors are inotropic and activation
enables calcium influx, cellular depolarization and vasoconstriction (118).

1.3

The Action Potential

The AP represents the fundamental neural signal enabling the sympathetic system to
communicate with the circulation. The prototypical AP arising from an unmyelinated
sympathetic c-fibre axon has a triphasic shape lasting one to two milliseconds in duration
that represents phases of membrane depolarization, repolarization and hyperpolarization,
and the return to resting membrane potential (54). APs are commonly described from the
perspective of intracellular preparations such as those revealing the first AP recordings
from the giant axons of squid by Hodgkin and Huxley (53, 54). Due to the relative
abundance of potassium ions (K+) in the intracellular fluid, and relative abundance of Na+
and chloride ions (Cl-) in the extracellular fluid along with the large concentration of
open resting K+ channels which facilitate K+ diffusion, most axons express a resting
membrane potential of about -60 to -70 mV (10, 92).
Changes in the permeability of these ions facilitated by voltage-gated Na+ and K+
channels underlie AP generation. At the resting membrane potential, voltage-gated Na+
channels are closed and passive spread of the AP depolarization at an upstream adjacent
axonal segment initiates channel opening leading to inward Na+ diffusion and rapid
depolarization of this region (i.e., the intracellular fluid becomes more positive resulting
in an AP upstroke) (77). Voltage-gated Na+ channels close at peak depolarization and
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remain inactivated for several milliseconds contributing to the refractory period of the
axonal segment which ensures orthodromic AP conduction (10). Cell depolarization
triggers transient voltage-gated K+ channel opening leading to K+ efflux causing
repolarization (i.e., the intracellular fluid becomes negative resulting in an AP
downstroke) and hyperpolarization (i.e., the intracellular fluid transiently becomes more
negative than the resting membrane potential) then returns to the resting membrane
potential (92). The AP hyperpolarization phase also produces a refractory stage,
contributing to orthodromic conduction (77). Because the tip of the microelectrode used
in microneurographic recordings is up to 10-fold larger in diameter than c-fibre axons
(124), recordings in humans yield extracellular sympathetic APs, which express the
reciprocal waveform to that described above (81, 98)

1.4

Muscle Sympathetic Nerve Activity

MSNA, postganglionic c-fibre discharge directed towards the skeletal muscle
vasculature, represents a critical neural avenue for homeostasis. In humans, the
microneurographic technique enables continuous MSNA recordings from superficial
nerves (49). Briefly, microneurography involves inserting a tungsten microelectrode
trans-dermally into a peripheral nerve and delicately manipulating the electrode to
position its tip, and recording field, near a discharging bundle of postganglionic axons
(106, 125). Populations of varying-sized postganglionic nerves depolarize synchronously,
or at about the same time, due to strong phasic baroreflex-inhibition accompanying
pressure variations across the cardiac cycle (26). This bursty behaviour represents a
cardinal feature of MSNA.
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Consistent with the first microneurographic recordings by Hagbarth and Vallbo (49),
MSNA is commonly measured at the multi-unit level, capturing the activity of a
population of c-fibres rather than individual nerves. Due to the low signal-to-noise ratio
of sympathetic recordings, after signal amplification (50,000 to 100,000x) and filtering
(700 – 2,000 Hz band-pass), researchers often derive metrics of sympathetic activity from
the integrated neurogram (51, 134). Inspection of the integrated neurogram reveals bursts
of MSNA that vary in size and occurrence under baseline conditions (49, 130). Integrated
bursts typically express latencies, i.e., the time from the R-wave corresponding to the
systolic pulse terminating the burst to the burst peak, between about 1.2 and 1.5 seconds
(35) and stems from all components of the sympathetic organization with most influence
arising from the conduction velocity of unmyelinated postganglionic nerves (~1.1 m/s)
(34, 35). Because burst size stems, in part, from the proximity of the recording electrode
to a c-fibre bundle and micro-electrode position can vary across an experiment, many
studies have solely examined burst frequency (51). While the strong intra-individual
repeatability over months confers utility to this metric (36, 67), the singular focus on
burst occurrence exposes insight to baroreflex mechanisms but conceals additional,
broader properties of the sympathetic nervous system (106). Based on the observation
that burst size was inversely related to its latency (130): that is, larger bursts expressed
faster conduction velocities than smaller bursts, Wallin and colleagues suspected that
modifiable central synaptic delays and/or subpopulations of larger and faster-conducting
axons may exist. This early hypothesis suggested that provided microelectrode position
remains stable, burst size (or amplitude) may reflect the number and size of
synchronously discharging postganglionic axons.
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Advances in the microneurographic technique, high quality recordings, and signal
processing strategies have enabled access to the actual sympathetic neural signal — the
AP (80, 104, 106). Macefield and colleagues were the first to reveal the firing properties
of individual vasoconstrictor fibres in humans (81). Reductions in the recording field
accompanying high impedance electrodes (e.g., 10 vs. 3 MW) enabled this group to track
the activity of APs arising from one (i.e., single-unit) or a few axons in close proximity to
the microelectrode tip. An important consideration with this technique remains that a
single-unit may be generated by two close-proximity axons with identical morphology,
though investigators suspect this describes a low-probability occurrence (80). This
technique exposed that in healthy participants, individual c-fibres fire in few cardiac
cycles (~30 %) and most often they fire only once in an integrated burst but can fire more
than 4 times in a burst (81). During an end-expiratory apnea, single-units fired in a
greater proportion of cardiac cycles and expressed an increased probability of firing more
than once per burst (79). However, multiple within-burst firing could not explain fully the
increase in integrated burst size, furthering the hypothesis that recruitment of previouslysilent larger and faster conducting axons may represent the primary mechanism for
augmented burst size (79).
To test the hypothesis that a subpopulation of previously silent, larger and faster
conducting sympathetic axons are recruited during physiological stress requires APs to be
detected and extracted from the multi-unit neurogram. Two wavelet denoising techniques
(16, 29, 98) and a mixed separation template-matching model (120) have been designed
to interrogate the multi-unit signal; however, most research has employed the wavelet
model constructed from real human muscle sympathetic APs (98, 110) and therefore the
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present dissertation will focus on this technique and related outcomes. Briefly, this
technique relies on a mother wavelet that was based on the mean AP template constructed
from real human muscle sympathetic APs (98). Using a continuous transform of the
filtered neurogram, the approach identifies the exact location of individual APs and
extracts them from the surrounding noise (98). Using a 32-point K-means approach
families of similarly-shaped APs are clustered based on their overall shape, primarily
reflecting the peak-to-peak amplitude (98). Subsequently, APs can be organized into bins
(i.e., clusters) manually or based on Scott’s rule (102). When used to compare multi-unit
data obtained during a baseline condition and a period of physiological stress, this
approach enables investigators to make inferences regarding the recruitment of
previously-silent larger APs (i.e., high-threshold) or the enhanced firing of previouslyactive APs (i.e., low-threshold), provided a constant micro-electrode position. Also, this
method exposes the temporal characteristics of individual APs: relative to adjacent APs,
the beginning of an integrated burst, and the R-wave associated with the systolic pressure
inhibiting the coinciding burst (98). Figure 1.1 provides an overview of wavelet method
for AP detection.
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Figure 1.1 Overview of the stages involved in extracting sympathetic action potentials
(AP) from the filtered neurogram using the continuous wavelet transform (98) including
signal processing, clustering, and binning.
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The wavelet approach has illustrated diverse behaviours expressed by the varying-sized
APs firing within the sympathetic multi-unit neurogram under baseline conditions and
during periods of physiological stress (103, 104, 106). These complex patterns of AP
activity — defined broadly as sympathetic communication strategies — are tailored to the
magnitude and form of stress and employed by the sympathetic nervous system to
communicate the circulatory adjustments necessary for homeostatic maintenance (106).
Among APs firing synchronously to form bursts, multiple size-related subpopulations
exist expressing heterogeneous discharge and recruitment characteristics that contribute
to fluctuations in burst size and occurrence over time. The firing probability of APs
active at baseline (i.e., low-threshold APs) varies by size to resemble an inverted ‘U’
shaped distribution as medium APs fire in most bursts, while the small and large APs
discharge less often (74, 101).
During diverse forms of physiological stress, two key AP patterns elevate total MSNA.
First, the sympathetic system utilizes a rate-coding strategy which defines the increased
firing of previously-active AP subpopulations achieved via a greater occurrence of
synchronized bursts of AP discharge and a greater propensity for multiple firing within
each burst of activity (79, 110). Because the wavelet approach does not track APs arising
from single fibres over time, rate-coding from this perspective refers to an increase in the
firing probability of similarly-sized APs (i.e., clusters) already active at baseline. Second,
during stress the sympathetic system utilizes a population-coding strategy which
describes the recruitment of larger and faster-conducting AP clusters that were not active
at baseline. These strategies appear to be reflex non-specific as they have been observed
during a host of stressors targeting the chemoreflex (3, 6, 88, 110), baroreflex (6, 74, 99–
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101), and metaboreflex (5) among other forms of physiological stress such as apnea (4,
69). Fig. 1.2 provides an overview of the varying-sized AP subpopulations contained
within the filtered neurogram.
Not all APs previously-active at baseline appear to increase firing rates with
physiological stress, however. During the hypotensive phase of a sodium nitroprusside
bolus infusion, Limberg and colleagues (74) found the cluster of the smallest APs
extracted using the wavelet technique to express a paradoxical reduction in firing
probability, while medium clusters fired more often and a subpopulation of larger and
faster-conducting APs were recruited. Studies from laboratories employing high
impedance electrodes to examine a few active APs provide evidence consistent with this
phenomenon. In a sample of young and middle-aged healthy individuals, Millar and
colleagues identified a subpopulation of APs that fired less often during modest LBNP (10 mmHg) and moderate rhythmic handgrip exercise (40 % max effort) (57, 85). While
the different microneurographic techniques preclude direct comparisons between studies,
these observations suggest that a subpopulation of sympathetic APs, perhaps arising from
the smallest postganglionic axons, may be inhibited during periods of sympathetic
arousal such as simulated orthostatic stress or physical exercise. If so, this feature aligns
with the de-recruitment or reduced firing of low-threshold motor neurons during periods
of high-threshold neuron activation as observed in decerebrate cats (64). This concept
remains to be studied directly for postganglionic sympathetic c-fibres.
The AP cluster latency represents a critical criterion for making inferences regarding
axonal size within the microneurographic recording field (110). In a similar manner to
measuring burst latency, AP latency represents the time from the R-wave associated with
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AP occurrence and the negative peak of the AP waveform (99). According to cable
theory, axonal size should be proportional to its conduction velocity and AP amplitude
(91, 121). Importantly, when regressing AP cluster latency against AP cluster size an
exponential decay relationship emerges consistently for AP data obtained at baseline and
physiological stress, indicating that larger APs arise from larger axons that express faster
conduction velocities (6, 69, 100, 110). This evidence argues against the notion that
larger APs reflect depolarization of axons closer to the microelectrode tip.
The temporal behaviour of AP discharge represents an additional strategy for modifying
MSNA. At baseline, Macefield and colleagues (81) reported considerable variation in
latency of single sympathetic axons, providing additional support for the idea that
variable synaptic delays exist in the central sympathetic organization. During both
Valsalva’s Manoeuvre and apnea, all AP clusters express reduced latency (4, 6, 69, 100).
Based on the observation that AP latency was reduced during isometric handgrip but
returned to baseline values in the subsequent period of circulatory occlusion suggests that
the central command mechanism related to perceptual effort may contribute to this
phenomenon (5). In contrast, severe baroreflex stress in the absence of perceptual stress
such as that imposed by -80 mmHg LBNP prolongs the latency of all AP clusters (6, 99).
The mechanisms shaping AP latency also appear chronically modifiable as exposure to
60-days of head-down bed rest increased the latency of all APs firing at baseline and
during apneic stress (69).
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Figure 1.2 Data from a single participant providing an overview of the discharge
characteristics associated with the varying-sized sympathetic action potential (AP)
subpopulations. Low-threshold APs are active under baseline conditions and are
comprised by three fundamental subpopulations small, medium, and large, as highlighted
on the right (see text for details). During physiological stress such as -80mmHg lower
body negative pressure (LBNP), some low-threshold APs increase their firing rate. Also,
a subpopulation of high-threshold larger APs are recruited during physiological stress.
Each panel illustrates AP discharge over time as a function of their diastolic blood
pressure (DBP; top) and cluster (left). AP cluster refers to all APs of similar morphology
and are normalized between conditions to ensure within-participant comparisons (e.g.,
cluster 1 represents the same-sized APs at BSL and LBNP). (Previous page).
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1.4.1

Baroreflex Control of Muscle Sympathetic Nerve Activity

As mentioned, pulse-rhythmic input from arterial baroreceptors shapes the bursty
behaviour of MSNA and contributes to the time-varying outflow of sympathetic
discharge (33). Arterial baroreflex control of MSNA can be derived by measuring
baroreflex gain, the strength of the relationship between baroreflex-mediated MSNA
changes and spontaneous blood pressure oscillations. Sundlöf and Wallin (116) designed
this strategy to examine baroreflex-mediated alterations in integrated burst probability
(i.e., baroreflex threshold analysis) and integrated burst amplitude (i.e., baroreflex
sensitivity analysis) for given changes in blood pressure. Commonly, baroreflex threshold
analysis involves grouping diastolic blood pressure into bins (e.g., 1 or 2 mmHg bin
width) and calculating the percentage of heartbeats per diastolic bin that were associated
with an integrated burst (50, 66, 101). The slope of the linear relationship between burst
probability and diastolic blood pressure represents baroreflex threshold gain.
Alternatively, baroreflex sensitivity examines the slope of the linear relationship between
amplitude of each burst and its corresponding diastolic blood pressure (50).
Comparison of baroreflex threshold and sensitivity measures by Kienbaum and
colleagues (66) demonstrated stronger baroreflex threshold than sensitivity slopes in each
participant during baseline. This finding spurred the baroreflex-gating hypothesis stating
that the baroreflex gates whether or not a burst will fire but other central neural processes
influence the size (i.e., AP content) of each burst. This notion aligns with the observation
that the severity of LBNP was positively related to the change in burst frequency from
baseline, while no relationship existed with the change in burst amplitude (117). In
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contrast, some forms of chemoreflex stress preferentially augment burst size over burst
frequency (82, 111).
To explain the observations regarding differential baroreflex regulation of burst
occurrence versus size, Salmanpour and Shoemaker (2012) studied the baroreflex control
of AP discharge by regressing AP firing probability of each cluster against diastolic
blood pressure (i.e., baroreflex threshold analysis). During baseline conditions this
approach revealed that the gain of baroreflex control over AP discharge linearly
decreases with increasing AP cluster size indicating that the arterial baroreflex strongly
governs small-to-medium AP discharge but exerts weak control over larger AP cluster
firing. Thus, the baroreflex strongly governs burst occurrence because it affects medium
AP firing, which occur in most bursts. Alternatively, burst amplitude is only minimally
affected by the arterial baroreflex because larger AP clusters express weak slopes and fire
less often. Also, because burst amplitude represents both the size and number of
synchronously firing APs (110), Salmanpour and Shoemaker (2012) examined the
relationship between the number of unique AP clusters per burst and the diastolic blood
pressure associated with that burst (i.e., baroreflex sensitivity analysis). This method also
revealed weak slopes, suggesting the baroreflex does not strongly govern within-burst AP
content (101). Together, the observation that larger AP clusters fire less often, express
weak baroreflex slopes but contribute more to integrated burst size, and that the
baroreflex weakly controls the number of AP clusters per burst, results in minimal
baroreflex control over burst amplitude. Consistent with these data are the repeated
findings that baroreflex stress (i.e., imposed by LBNP or sodium nitroprusside) weakly
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recruits subpopulations of larger and faster conducting APs, at least until severe levels of
baroreflex unloading in some individuals (6, 74, 99).

1.5

Integrated Rationale

As illustrated in the discourse above, single- and multi-fibre microneurographic
recordings have revealed an array of intricate behaviours contained within the
sympathetic discharge directed towards the circulation supplying skeletal muscle (80,
106). Fundamentally, the complexity of sympathetic neural emissions stems from the
heterogenous firing probabilities expressed by sized-related AP subpopulations. Of APs
synchronized into bursts under baseline conditions (i.e., low-threshold APs), medium
APs fire in most bursts, whereas the small and large APs fire less often (101, 110). These
low-threshold APs are critical for communicating with the vasculature and supporting
homeostasis in humans under baseline conditions. Given that postganglionic emissions
reflect the central and peripheral organization of the sympathetic system (59),
heterogenous discharge behaviours among AP subpopulations suggest differential
regulatory mechanisms. While the arterial baroreflex governs the behaviour of some lowthreshold APs during baseline (101), other neural mechanisms affecting AP patterns
remain to be investigated.
To maintain homeostasis during physiological stress the sympathetic system employs two
key strategies to increase total MSNA. First, the sympathetic system increases the firing
rate of previously-active APs, then during severe stress, the system recruits a
subpopulation of latent larger and faster-conducting APs (5, 99). Recently, research
efforts have been dedicated to understanding the discharge patterns and reflex
mechanisms governing larger previously-silent (i.e., high-threshold) sympathetic APs (3,
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4, 6), yet the AP subpopulations expressing heterogenous discharge under baseline
conditions and augmented firing probabilities during physiological stress have received
less attention.
Therefore, the present dissertation proposed the overall objective to investigate the
behaviour and mechanisms governing the low-threshold (i.e., active at baseline)
sympathetic AP subpopulations. This dissertation tested the overall hypothesis that
heterogeneous discharge behaviour exists among varying-sized low-threshold AP
subpopulations under baseline conditions and during physiological stress, due to differing
regulation within the sympathetic organization. While each study addresses the overall
objective and hypothesis in a specific way, the following discourse highlights the logical
succession of studies that emerged with our observations.
At the paravertebral ganglia, patterns of divergent and convergent pre- to postganglionic
innervation amplify distribution and confer complexity to the discharge of varying-sized
sympathetic c-fibres (42, 84), respectively. In fact, synaptic convergence appears to vary
by sympathetic postganglionic neuron size in lower animals (93, 94), a feature which
may produce AP size-related firing characteristics. Therefore, Study One (71) tested the
hypothesis that the paravertebral ganglia contribute to the discharge behaviour of
sympathetic APs active at baseline in humans. Two novel findings emerged from this
study: 1) Trimethaphan infusion produced ordered AP de-recruitment whereby the large
APs firing with low probability during baseline were abolished first, followed by the
reduced discharge probability of smaller APs; 2) Although trimethaphan infusion blocked
integrated bursts of MSNA, we observed the smallest APs to express trimethaphanresistance and fire in an asynchronous manner. We interpret these observations to suggest
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that the ganglia contribute to the heterogeneous discharge patterns among varying-sized
APs due to differential patterns of ganglionic synaptic input. Also, we hypothesize that
the trimethaphan-resistant property of smaller APs reflects non-nicotinic mechanisms
(60), which participate in neurotransmission at the human sympathetic ganglia.
The primary characterization of MSNA to date focuses on pulse-rhythmic bursts formed
by the synchronized discharge of varying-sized APs (49, 110). But observations made in
Study One (71) and studies in lower animals (14, 15) suggest that some sympathetic cfibres may express non-burst forming asynchronous discharge, and that the ganglia may
participate in this behaviour (15). Therefore, Study Two (72) tested the hypothesis that
synchronous and asynchronous discharge exist among sympathetic APs and the ganglia
affect AP synchronicity. By studying all APs rather than just those within identified
bursts, we found that: 1) At baseline, ~30% of total sympathetic AP discharge fired
asynchronously, between bursts; 2) The probability of asynchronous discharge was
related inversely to AP cluster size and the asynchronous AP discharge frequency was
not affected by baroreflex or apneic stress; 3) While the largest asynchronously firing AP
clusters present at baseline were blocked by trimethaphan infusion, the smaller
asynchronous APs persisted to fire. We interpret these findings to suggest that the
fundamental behaviour of MSNA contains between-burst asynchronous AP discharge,
which accounts for a considerable amount of baseline activity, and the ganglia contribute
to some, but not all asynchronous AP firing.
Pulse-rhythmic arterial baroreceptor input synchronizes APs into bursts (33) and of the
APs organized into these bursts, arterial baroreflex control relates inversely to AP cluster
size under baseline conditions (101). However, our understanding of baroreflex AP

33

control remains unclear given that Study Two found ~30% of total APs to fire
asynchronously outside baroreflex-gated bursts at baseline, with the smallest APs
expressing the greatest proportion of asynchronous discharge (72). Combined with the
finding that the baroreflex primarily relies on augmenting the firing probability of
previously-active APs to maintain blood pressure during orthostatic stress (99), these
observations warrant an investigation into the heterogeneity of baroreflex control over
AP discharge. Accordingly, Study Three tested the hypothesis that the baroreflex exerts
the strongest gain over medium-sized APs that fire with high probability under baseline
conditions, and the change in position and slope of each clusters baroreflex curve
accompanying orthostatic stress should vary across the distribution of recorded APs.
Here, by studying all active APs, we found that medium APs expressed the greatest
baroreflex gain while the smallest and largest clusters expressed lesser gains during
baseline conditions. On going from baseline to baroreflex stress, the baroreflex gain for
each AP cluster was modified differently: the medium AP slopes increased, while the
slopes for the small and large APs present at baseline exhibited a reduction and no
change, respectively. Also, the larger AP clusters that were silent at baseline but recruited
during orthostatic stress expressed weak baroreflex gains. From these findings we infer
that resetting the activity upwards and augmenting the gain of a discrete group of medium
APs already active at baseline, as well as the recruitment of a non-baroreflex highthreshold subpopulation, elevates sympathetic discharge during baroreflex stress in
humans.
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Chapter 2

2

The role of the paravertebral ganglia in human
sympathetic neural discharge patterns

Published in The Journal of physiology: 596(18), 4497-4510, 2018.

2.1 Introduction
The ganglia determine the extent to which the sympathetic nervous system communicates
central intentions to the peripheral vasculature supplying skeletal muscle (13). The
ganglia participate in spatial amplification of efferent sympathetic outflow through
synaptic divergence of a distribution of primary “strong” synapses (19, 35). Also,
patterns of pre-to-postganglionic convergent innervation have been observed in rodent
and amphibian models (41, 52). As the degree of convergence appears to scale with
neuron size in mammals (39, 40), it would be expected to add greater complexity to the
temporal and spatial summation of excitatory post-synaptic potentials (EPSP).
The synchronization of differently-sized action potentials (AP) into bursts of activity
represents a fundamental characteristic of sympathetic activity, readily observed in
neurograms of sympathetic nerve activity directed towards the vasculature of skeletal
muscle (MSNA). Furthermore, multi-unit and single-unit recordings of axonal firing
patterns within MSNA bursts have revealed additional layers of complexity regarding
communication strategies contained within the sympathetic neural signal in humans (31,
47, 51). For instance, under baseline conditions, recruited axons fire with relatively low
probability [e.g., 21% of cardiac cycles (32)]. In addition, multi-unit AP recordings show
that as a population, firing probabilities of differently-sized APs (probably not the same
axon) tend to vary with AP size in an inverted “U” manner, such that the smallest AP
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clusters and largest AP clusters express low within-burst probabilities whereas
moderately-sized AP clusters are expressed frequently, with some occurring in every
burst (28, 45, 54). Furthermore, acute homeostatic challenges (e.g., apneic, metabolic,
and orthostatic stress) reveal an orderly recruitment strategy where the sympathetic
system expresses options of increasing the firing probability of already-active APs and, in
high stress, recruitment of a subpopulation of latent, larger and faster-conducting APs (2,
43, 54). Further, the timing of a recruited AP may be modified by synaptic delays (11,
61): a feature which we hypothesize to be mediated in part, by perceptual mechanisms (3,
26, 44). These ordered patterns of postganglionic AP behaviour and recruitment infer
heterogeneous regulation of sympathetic neurons. However, the neural sites within reflex
arcs and/or descending sympathetic pathways that exert influence over these discharge
patterns remain uncertain.
Even at the level of the integrated sympathetic signal, the neural circuitry involved in
MSNA control remains unclear. While the brainstem network forming the arterial
baroreflex represents perhaps the most thoroughly studied site of sympathetic regulation,
contributing to the pulse-synchronous “bursty” nature of the signal (53), evidence also
points towards baroreflex-independent pathways as a source of MSNA patterns,
especially fluctuations in burst amplitude, which are dependent on AP content (23, 33).
For example, supra-medullary sites are involved in regulating sympathetic outflow (4, 15,
25, 48, 57), including the variability in burst size (56). To date, however, few
investigations have studied the contribution of other, non-baroreflex sites within the
sympathetic system, to patterns of sympathetic discharge, such as spinal (55) or
ganglionic mechanisms.
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This study tested the hypothesis that the paravertebral ganglia contribute to ordered
patterns of sympathetic AP discharge at baseline in humans. To address this hypothesis,
we examined the impact of paravertebral ganglionic blockade (via intravenous
trimethaphan camsylate) on multifibre recordings with microneurography at the peroneal
nerve in female participants.

2.2
2.2.1

Methods
Ethical Approval

All procedures were approved by the Mayo Clinic Institutional Review Board (No. 09008548) and the study conformed to the standards set by the Declaration of Helsinki,
except for registration in a database. All participants provided written, informed consent
after receiving verbal and written instructions outlining the experimental protocol.

2.2.2

Participants

This study evaluated data from seven healthy females (37 ± 5 years, 165 ± 2 cm, 60 ± 4
kg, 22 ± 1 kg/m2, 25 ± 3 % body fat). On a separate day prior to the testing session,
participants performed health screening to determine that all fit study inclusion/exclusion
criteria: non-smoker, systolic blood pressure (BP) <150 mmHg, diastolic BP <95 mmHg,
body mass index <30 kg/m2, and no history of diabetes or cardiovascular diseases. All
participants provided a negative pregnancy test result within 48 h. Pre-menopausal
women (n = 5) were tested in the early follicular stage of the menstrual cycle (days 2-6 of
menses) or the placebo phase for young women on oral contraceptives (n = 2, participant
identifiers TM59 and TM63, both taking levonorgestrel and ethinyl estradiol). No other
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participants were taking medications. Two participants were post-menopausal (n = 2,
participant identifiers TM32 and TM50, 7 and 6 years since last menses, respectively).

2.2.3

Experimental Procedures

Participants arrived at the laboratory after an overnight fast and refraining from heavy
exercise, caffeine, and alcohol for 24 h before the study. Participants assumed the supine
position for instrumentation and data collection. After local anesthetic with 2% lidocaine,
a 5-cm 20-gauge arterial catheter was placed in the brachial artery of the non-dominant
arm, using aseptic technique. The catheter was connected to a pressure transducer,
positioned at heart level to record continuous arterial BP. A 3-lead electrocardiogram
(ECG) recorded continuous heart rate (HR). Research personnel placed an intravenous
catheter in the contralateral arm for drug infusion.

2.2.4

Experimental Design

Data were collected during baseline and the trimethaphan camsylate infusion (1-7
mg/min; Cambridge Laboratories, Wallsend, United Kingdom). Trimethaphan infusion
rate was adjusted over time, though this varied across participants. During the
trimethaphan infusion, once cessation of integrated MSNA burst activity occurred,
participants were instructed to perform a 20 s Valsalva’s Manoeuvre with an expiratory
mouth pressure of 40 mmHg. After discontinuation of the study and de-instrumentation,
subjects remained in the Clinical Research Unit for ≥ 2 hours for observation.
Data analysis was conducted for four study conditions: 1) 5-min baseline (309 ± 28 s), 2)
minute-by-minute of the trimethaphan infusion where integrated sympathetic bursts were
visible and AP analysis could be performed [note that the last “minute” was 89 ± 17 s to
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provide a suitable number of bursts for analysis], 3) two minutes (120 ± 0 s) of the
trimethaphan infusion where sympathetic bursts were not visible, and 4) a Valsalva’s
Manoeuvre performed during the trimethaphan infusion where sympathetic bursts were
not visible (23 ± 7 s).

2.2.5

Experimental Measures and Analysis

Efferent multiunit MSNA was measured from postganglionic C-fibres in the peroneal
nerve by microneurography (14) as detailed recently (26). Integrated bursts of MSNA
were analyzed if they were pulse-synchronous, had a signal-to-noise ratio of at least 2:1
relative to the previous period of neural silence, and expressed characteristic rising and
falling slopes. MSNA bursts were inspected for consistent amplitude to rule out shifts in
microelectrode position.
At the integrated level, sympathetic activity was quantified as burst frequency
(bursts/min) and burst incidence (bursts/100 heartbeats). Burst amplitude (AU) was
measured in volts and normalized to the max burst amplitude at baseline, which was
given a value of 100. Total MSNA (AU/min) was measured as the product of burst
frequency and amplitude. Sympathetic burst latency was measured as the mean time
interval (s) from the preceding ECG R-wave, to the peak of the corresponding MSNA
burst in the integrated neurogram (12).
Postganglionic sympathetic APs were detected and extracted from the filtered raw
MSNA signal using a continuous wavelet transform, which has been described in detail
previously (42). At baseline and during trimethaphan infusion where integrated bursts
were visible, APs were only extracted if they occurred within an integrated burst (i.e.,
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0.8s around the peak of the burst). Alternatively, during trimethaphan infusion where
integrated bursts were no longer visible, any AP that occurred was extracted. With both
techniques, extracted APs were ordered based on peak-to-peak amplitude, and histogram
analysis was performed to separate APs into amplitude-based clusters. Cluster bin widths
for baseline data were automatically defined based on Scott’s rule which balanced bin
width, data bias and variance to minimize the integrated mean square error (46). Thus,
the number of total clusters at baseline varied by participant. AP data collected during the
different periods of the trimethaphan infusion (i.e., MSNA bursting period, non-bursting
period, and Valsalva’s Manoeuvre) were normalized to baseline for each participant to
ensure that bin width, maximum bin centre, and the total number of bins would be
identical across conditions. APs that were not detected during trimethaphan were
considered de-recruited from baseline. The signal-to-noise ratio was determined as the
amplitude of the negative peak of the mean AP over the standard deviation of the
background noise. Based on our previous simulations, the signal-to-noise ratio of the
multi-unit AP signal obtained at baseline (4.2 ± 0.7) and during trimethaphan (4.2 ± 0.5)
was expected to produce a correct detection rate of > 90% and a false positive rate of
<3% (42).
AP indices included AP frequency (APs/minute), incidence (APs/100 beats), and the
mean AP content per integrated burst. Also, the number of total clusters detected and the
number of active clusters per integrated burst were assessed. AP latency was determined
as the time delay from the R-wave of the preceding cardiac cycle to the negative peak of
the AP (44). AP cluster latency was determined as the mean latency of all APs within a
cluster. AP cluster firing probability distributions were constructed to evaluate the firing
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probability of each sympathetic AP cluster at baseline and the final minute of bursting
activity during the trimethaphan infusion. To do so, we divided the number of times an
AP cluster fired by the total number of bursts that occurred in a given condition,
multiplied by 100%. A probability of 100% indicates that the cluster fired once in every
integrated burst, whereas a probability of less than, or greater than, 100% indicates that
the cluster was not active in every burst, or occasionally fired more than once per burst,
respectively.
HR and BP were collected at 1,000 Hz. The mean values for HR and mean arterial
pressure (MAP) were calculated for all conditions. All signals were sampled using
PowerLab (ADInstruments; Castle Hill, New South Wales, Australia) and stored on a
computer for subsequent analysis. Researchers were not blinded during analysis.

2.2.6

Statistical Analysis

This study tested the hypothesis that the ganglia contribute to patterns of postganglionic
sympathetic AP discharge at baseline in humans. All data are presented as mean ± SD.
Due to the inter-individual variability in magnitude and time course of the nicotinic
blockade, minute-by-minute changes in all sympathetic indices with trimethaphan
infusion were not evaluated statistically. Accordingly, paired sample t-tests were
employed to assess differences between: 1) baseline versus the last minute of bursting
activity during the trimethaphan infusion, and 2) the non-bursting period of the
trimethaphan infusion versus the responses to Valsalva’s Manoeuvre. For AP clusters
expressing trimethaphan-resistance, a repeated-measures analysis of variance (RM
ANOVA) assessed changes in AP incidence across baseline, the last minute of the
trimethaphan infusion with visible bursts, and the period of the trimethaphan infusion
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without visible bursts. Linear regression was performed to assess the relationship
between normalized integrated burst amplitude and AP content per burst. Statistical
analysis was performed using SPSS (v 23, SPSS Inc., Chicago, IL). Tests were two tailed
with α = 0.05. Each unique symbol represents the same participant’s data across figures
depicting individual data.

2.3

Results

Fig. 2.1 illustrates one participant’s response to trimethaphan infusion, particularly the
reductions in integrated bursting activity (Fig. 2.1 A1) and the discharge patterns of
sympathetic AP clusters during drug infusion (Fig. 2.1 A2). These results compare
baseline to the last minute of visible bursting activity that was suitable for AP analysis
during the trimethaphan infusion, unless specified otherwise. The mean time from
infusion start to burst cessation was 523 ± 242 s. At this time, the infusion rate was 2 ± 1
mg/min. Trimethaphan infusion was associated with an increase in HR (baseline versus
final minute of trimethaphan condition with MSNA bursts: 57 ± 11 to 66 ± 12 bpm, P <
0.01) and a reduction in MAP (97 ± 7 to 90 ± 7 mmHg, P < 0.01) compared to baseline
(Fig. 2.2). Relative to baseline, trimethaphan elicited a progressive reduction in total
sympathetic outflow (833 ± 458 to 157 ± 120 AU/min, P < 0.01), characterized by fewer
integrated bursts (burst frequency: 17 ± 9 to 5 ± 4 bursts/min, P = 0.01; burst incidence:
30 ±14 to 9 ±8 bursts/100beats, P < 0.01) with decaying amplitude (49 ± 3 to 31 ± 3 AU,
P < 0.01) (Fig. 2.3). Underlying trimethaphan-mediated attenuations in the integrated
MSNA signal were reductions in AP frequency (104 ± 65 to 17 ± 17 AP/min, P = 0.01)
and incidence (186 ± 101 to 29 ± 31 AP/100beats, P < 0.01) as well as attenuated AP
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content per integrated burst (7 ± 2 to 3 ± 1 AP/burst, P < 0.01) (Fig. 2.4). When detected
APs were binned according to peak-to-peak amplitude, the total number of active AP
clusters was reduced with trimethaphan (14 ± 3 to 8 ± 2, P < 0.01), resulting in fewer
unique clusters firing per burst (4 ± 1 to 3 ± 1 clusters/burst, P < 0.01) (Fig. 2.4).
Trimethaphan infusion did not affect the latency of MSNA bursts (1.25 ± 0.05 to 1.22 ±
0.05) or APs (1.18 ± 0.06 to 1.16 ± 0.07 s) (both P > 0.12).
Closer analysis of the within-burst AP cluster firing patterns revealed a distribution of
firing probabilities that scaled to AP cluster size in an inverted “U” manner. At baseline,
moderately-sized clusters fired with high probability (i.e., approximately every burst),
whereas the smallest AP clusters and largest AP clusters expressed low within-burst
probabilities across all participants. In the last minute of visible bursting activity during
the trimethaphan infusion, participants demonstrated a reduction in the firing probability
of the majority of AP clusters with the largest AP clusters (range: 4 to 10 largest clusters)
ceasing to fire, moderately-sized cluster firing displaying moderate declines in
probability, and generally no change in the activity of smaller clusters. Firing probability
distributions for each participant (Fig. 2.5A) enable visualization of the between-subject
variability in active cluster number and the extent of large cluster de-recruitment with
trimethaphan, whereas, the group averaged normalized distributions (Fig. 2.5B) show a
similar pattern of reduced cluster firing probability with trimethaphan but allow statistical
comparisons between baseline and trimethaphan.
At baseline, AP cluster latency decreased as a function of normalized cluster number
(i.e., as peak-to-peak AP cluster amplitude increased) (R2 = 0.67, P < 0.01). Because

54

trimethaphan abolished the firing of the largest clusters, the AP cluster latency-size
relationship was examined for the entire condition (i.e., from infusion start until the last
minute of visible bursting activity) and was not restricted to the final minute of bursting
activity. Here, the same general pattern was observed, but did not reach significance (R2
= 0.28, P = 0.11). The mean AP cluster latency-size responses were fitted using an
exponential decay function (Fig. 2.6). These relationships support the concept that AP
cluster size scaled to the diameter of sympathetic C-fibres within the recording field of
the micro-electrode.
At baseline, linear regression indicated moderate-to-strong relationships between relative
integrated burst size and the number of APs per burst (y = 0.14 ± 0.05x – 0.37 ± 0.55, r2 =
0.57 ± 0.17, all P < 0.01), normalized integrated burst amplitude and AP clusters per
burst (y = 0.05 ± 0.02x + 1.64 ± 0.31, r2 = 0.37 ± 0.21, all P < 0.01), and the number of
AP clusters per burst and the number of APs per burst (y = 0.33 ± 0.05x + 1.78 ± 0.13, r2
= 0.60 ± 0.13, all P < 0.01). In the last minute of visible bursting activity during the
trimethaphan infusion, the same fundamental relationships were observed, though these
were not significant in all participants (integrated burst size vs. the number of APs per
burst: y = 0.12 ± 0.08x + 0.02 ± 3.3, r2 = 0.30 ± 0.25, P < 0.05 in n = 3 of 7 participants,
normalized integrated burst amplitude vs. AP clusters per burst: y = 0.04 ± 0.05x + 1.65 ±
2.0, r2 = 0.19 ± 0.16, P < 0.05 in n = 2 of 7 participants, and the number of AP clusters
per burst vs. the number of APs per burst: y = 0.36 ± 0.25x + 1.28 ± 0.62, r2 = 0.56 ±
0.33, P < 0.05 in n = 5 of 7 participants). Figure 2.7 illustrates these relationships for one
participant.
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During the period of the trimethaphan infusion where integrated bursts were no longer
visible (120 ± 0 s, 80 ± 6 bpm, MAP: 87 ± 12 mmHg), we observed the discharge of a
population of trimethaphan-resistant APs. In all seven individuals, these APs were the
smallest 6 ± 2 sympathetic AP clusters (range: 4 – 8 AP clusters) present at baseline,
firing in an asynchronous pattern (i.e., visual inspection showed no apparent baroreflexmediated pulse rhythmicity) with a frequency of 38 ± 32 AP/min (49 ± 41 AP/100beats)
(Figure 1 B1 and B2). Compared to baseline (118 ± 61 APs/100beats), trimethaphanresistant clusters (i.e., not clusters de-recruited by trimethaphan), demonstrated reduced
incidence in the last minute of visible bursts during trimethaphan infusion (26 ± 24
APs/100beats, simple-effects paired t-test: P < 0.01) as well as during the period of the
trimethaphan infusion without visible bursts (49 ± 41 APs/100beats, simple-effects paired
t-test: P: < 0.05; RM ANOVA: P < 0.05). There were no differences in the incidence of
trimethaphan resistant clusters between the final minute of visible bursts during
trimethaphan and the period of the trimethaphan without visible bursts (simple-effects
paired t-test: P > 0.3).
While trimethaphan infusion continued, research personnel instructed participants to
perform a Valsalva’s Manoeuvre. Valsalva’s Manoeuvre (28 ± 9 and 24 ± 7 mmHg
reduction in MAP and PP, respectively, from baseline to phase II, both P < 0.01) failed to
elicit integrated MSNA bursts in six of seven participants. When examining the data from
the six individuals with absent MSNA responses to Valsalva’s Manoeuvre only,
compared to the period of the trimethaphan infusion where trimethaphan-resistant APs
were observed, but integrated bursts were not visible (38 ± 32 AP/min; 49 ± 41
APs/100beats), the Valsalva’s Manoeuvre did not increase the firing frequency of
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trimethaphan-resistant APs (49 ± 32 AP/min, 60 ± 42 AP/100beats; both P > 0.30, both d
≤ 0.21, n = 6), nor were additional larger APs recruited (6 ± 1 clusters, P = 0.30, n = 6).

57

Figure 2.1 Representative recordings of heart rate (HR), blood pressure (BP), and the
integrated muscle sympathetic nerve activity (MSNA) neurogram from one individual.
Data were collected during the trimethaphan infusion where integrated MSNA bursts
were detected (A1) and during the trimethaphan infusion where integrated MSNA bursts
were no longer visible (B1). The associated pattern of action potential (AP) activity
during the trimethaphan infusion where integrated MSNA bursts were detected (A2) and
during the trimethaphan infusion where integrated MSNA bursts were no longer visible
(B2) is illustrated. A2: AP occurrence within each burst as a function of their cluster
(illustrated along the left). Cluster refers to all APs of similar morphology. B2: Because
no bursts were detected, all AP activity was extracted and presented as a function of their
cluster. APs extracted during trimethaphan infusion were normalized to baseline.
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Figure 2.2 Systolic (SBP; A), diastolic (DBP; B), mean arterial pressure (MAP; C), and
heart rate (HR; D) at baseline (BSL) and during each minute of the trimethaphan infusion
where integrated sympathetic bursts were visible. Minute-by-minute data are presented
by line graphs with each unique symbol representing the same participant’s data across
figures depicting individual data. Mean ± SD for BSL and the last minute of detectable
integrated sympathetic bursting activity during the trimethaphan infusion (Last min) are
represented by half-filled circles and error bars. *, indicates significantly different from
Last min, P < 0.01.
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Figure 2.3 Integrated muscle sympathetic nerve activity (MSNA) burst frequency (BF;
A), burst incidence (BI; B), normalized burst amplitude (C), and total activity (D) at
baseline (BSL) and during each minute of the trimethaphan infusion where integrated
sympathetic bursts were visible. Minute-by-minute data are presented by line graphs with
each unique symbol representing the same participant’s data across figures depicting
individual data. Mean ± SD for baseline and the last minute of detectable integrated
sympathetic bursting activity during the trimethaphan infusion (Last min) are represented
by half-filled circles and error bars. *, indicates significantly different from Last min, P <
0.01.
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Figure 2.4 Sympathetic action potential (AP) frequency (A), AP incidence (B), APs per
burst (C), AP clusters per burst (D), and total AP clusters (E) at baseline (BSL) and
during each minute of the trimethaphan infusion during the period where integrated
sympathetic bursts were visible. Minute-by-minute data are presented by line graphs with
each unique symbol representing the same participant’s data across figures depicting
individual data. Mean ± SD for baseline and the last minute of detectable integrated
sympathetic bursting activity during the trimethaphan infusion (Last min) are represented
by half-filled circles and error bars. *, indicates significantly different from Last min, P <
0.01.
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Figure 2.5 Sympathetic action potential (AP) cluster probability distributions for each
participant at baseline (BSL) and the last minute of visible integrated sympathetic
bursting activity during the trimethaphan infusion (TM Last Min) (A). Group averaged
sympathetic AP probability distributions for BSL and TM Last Min with AP clusters
normalized to the largest cluster at baseline (B). For both individual and group averaged
figures a probability of 100% indicates that the cluster fired once in every integrated
burst, whereas a probability of less than or greater than 100% indicates that the cluster
occasionally fired more than once per burst or was not active in every burst, respectively.
*, indicates significantly different from TM Last Min within cluster, P < 0.01. (Previous
page).
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Figure 2.6 Action potential (AP) cluster latency as a function of AP cluster size at
baseline (BSL) and during the entire trimethaphan infusion. The decrease in cluster
latency as a function of amplitude was fit with an exponential decay function. Data
presented are group mean (SD).
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Figure 2.7 The number of sympathetic action potentials (AP) per burst as a function of
relative integrated burst amplitude (normalized to the largest burst at baseline and during
the trimethaphan infusion) at baseline (A1) and the last minute of detectable integrated
sympathetic bursting activity during the trimethaphan infusion (A2). The number of
unique sympathetic AP clusters per burst as a function of relative integrated burst
amplitude at baseline (B1) and the last minute of detectable integrated sympathetic
bursting activity during the trimethaphan infusion (B2). The number of unique AP
clusters per sympathetic burst as a function of the number of APs per burst at baseline
(C1) and the last minute of detectable integrated sympathetic bursting activity during the
trimethaphan infusion. Data presented are from one individual.
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2.4

Discussion

The current study provides new evidence regarding the role of the paravertebral ganglia
in the emission patterns of sympathetic postganglionic nerves directed towards the
skeletal muscle vasculature. First, we demonstrate that blockade of nicotinic receptors at
the ganglia elicited an ordered pattern of AP de-recruitment beginning with larger APs
that fire with lower probability under baseline conditions, followed by the progressive
decreased probability of smaller APs. Second, following trimethaphan-mediated
cessation of integrated MSNA bursts, small AP clusters persisted to fire in an
asynchronous pattern. Also, Valsalva’s Manoeuvre did not increase the firing rate of
these persistent AP clusters, or elicit recruitment of larger APs that had previously been
inhibited by trimethaphan. We interpret these observations to suggest: 1) the
paravertebral ganglia contribute to the heterogeneity in the firing probabilities of
differently-sized postganglionic sympathetic APs active under baseline conditions, and 2)
the presence of non-synchronized APs that express resistance to blockade with
trimethaphan.
Variations in integrated burst amplitude reflect the number and size of APs synchronized
to fire at about the same time (37, 43). Varying sized APs express a heterogeneity of
firing probabilities, such that, compared to moderately-sized APs, larger and smaller APs
contribute to considerably fewer bursts, while a subpopulation of even larger APs are
recruited during severe stress (45, 54). Focusing on baseline data only, ganglionic
blockade in the current study produced an ordered pattern of de-recruitment where larger
APs were inhibited, reducing burst size, followed by blockade of most small AP clusters,
rendering integrated bursts from being detected. As these data were collected as part of a
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larger study, waiting for metabolism of trimethaphan and subsequent return of MSNA
signal was not possible. Therefore, we cannot rule out the possibility that reductions in
burst size and AP cluster firing as well as the cessation of bursts following blockade were
attributed to changes in microelectrode position. However, this is unlikely given the
observation that small AP clusters were present through the entire study and no changes
in background signal intensity were observed.
Whereas trimethaphan exerted early effects on larger AP clusters, our previous studies
suggest that these clusters must express a higher threshold for recruitment (54). Also,
based on replicated evidence that larger AP clusters express faster conduction velocity
(26, 43) we expect that larger AP clusters reflect neurons with larger axons. Together,
these observations indicate that the larger AP clusters express a higher threshold for
recruitment and also a higher sensitivity for de-recruitment through a post-junctional
nicotinic mechanism. These data indicate that the ganglia participate in the recruitment
probability of larger AP clusters. Furthermore, the observation that medium-sized APs
exhibited moderate reductions in firing probability but were still active in the final minute
of MSNA bursting during trimethaphan infusion suggests that the ganglia express some
differential organization for postganglionic recruitment by neuron size.
We speculate that this pattern of recruitment and de-recruitment may reflect a scaling of
preganglionic synaptic input strength at the ganglia. However, the neural mechanisms
mediating such a preganglionic effect are not known. To our knowledge, beyond the
investigations using ganglionic blockade as a model of the circulation under negligible
autonomic control (21, 34) or delineating the origins of the integrated sympathetic signal
(10), no previous study has examined the role of the ganglia in human sympathetic AP
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discharge. While earlier studies in animals may provide some insight to the mechanisms
(e.g., ganglionic convergence) contributing to the present observations, the focus on
compound APs or single-unit recordings in these investigations (5, 17, 22, 38, 41, 52)
prevent direct comparisons with the current observations. Interestingly, compared to
moderately-sized APs that express strong baroreflex modulation, larger APs are weakly
associated with fluctuations in diastolic BP, suggesting that additional sites of control
beyond the arterial baroreflex participate in the regulation of the larger, low probability
APs (45). Similar conclusions have been drawn based on the observation that burst
occurrence, but not size, was related to diastolic BP in humans (23), causing this latter
group, and others (33) to speculate on sites outside of the baroreflex pathways that affect
burst size (analogous to large AP cluster recruitment). Consistent with this idea, both
magnetic resonance imaging and electroencephalographic studies suggest the
involvement of neural regions beyond the baroreflex brainstem nuclei in the regulation of
MSNA (15, 24, 27, 56). In this conjecture, the strength of preganglionic inputs to
postganglionic neurons possessing larger diameter axons, would reflect a subpopulation
of descending neural signals from higher cortical sites that are not under direct baroreflex
regulation.
The second major observation of the current study was a population of smaller AP
clusters that persisted to fire in an asynchronous manner, without consistent baroreflex
rhythmicity, following blockade of nicotinic receptors. To our knowledge, this
phenomenon has not been reported previously in humans. While these APs may not have
been sympathetic, this is unlikely as they exhibited similar morphological characteristics
to the smaller AP clusters that were synchronized to fire within bursts at baseline and
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during the trimethaphan infusion when integrated bursts were visible. This observation
also suggests that these clusters did not represent a new population of APs recruited
following trimethaphan. Also, an incomplete ganglionic blockade likely did not produce
these APs as, in six of seven individuals, Valsalva’s Manoeuvre performed during the
non-bursting period of trimethaphan infusion failed to elicit the recruitment of larger AP
clusters or integrated bursts (44). From these data, we surmise that they represent
spontaneous firing of postganglionic axons that normally receive cardiac entrainment via
descending baroreflex inputs and/or are controlled by non-nicotinic synaptic mechanisms
at the human paravertebral ganglia. Previous studies have documented spontaneous
neuronal activity within the medullary sites governing sympathetic discharge (9) and
while this evidence raises the possibility of spontaneous postganglionic spiking, this idea
has not been tested. Alternatively, detailed studies in feline and rodent models showed
persistent postganglionic activity during nicotinic blockade, illustrating the contribution
of non-nicotinic mechanisms to ganglionic signaling (16, 20, 60). Also, ganglionic
exposure to muscarinic agonists appears to enhance postganglionic nerve activity across
several studies (7, 60). Janig et al. (1983) further showed that chemoreflex-induced
discharge was evident in some, but not all postganglionic neurons during combined
nicotinic and muscarinic (atropine) blockade. In the bullfrog, peptide neurotransmitters
(including substance P and a peptide resembling luteinizing hormone releasing hormone)
contribute to postganglionic EPSPs (18). Thus, the most direct explanation of the
trimethaphan resistant AP clusters in the current observations is that they represent a
population of neurons with non-nicotinic synaptic mechanisms.
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The purpose of non-nicotinic ganglionic neurotransmission remains unclear. This feature
does highlight the complex nature of sympathetic neuronal recruitment. Interestingly,
repetitive preganglionic nerve stimulation exposes two phases of postganglionic activity
in vertebrates: These phases are a rapid onset, high frequency discharge mediated by
nicotinic receptor actions, and a delayed, low frequency firing pattern evoked by
muscarinic and peptidergic mechanisms (18, 20, 60). The purpose and mechanism(s)
supporting the trimethaphan-resistance of the smallest AP clusters remains unknown,
although the observation may be consistent with the conjecture that the ganglia also
participate in axonal size-related recruitment patterns. It is noted, however, that
baroreflex unloading via mild (36) and moderate-to-severe lower body suction (3, 43), or
sodium nitroprusside infusion (28), result in a paradoxical decrease in the firing of some
APs including smaller clusters, supporting the notion that complex mechanisms may
regulate small AP patterns.
An additional explanation for the trimethaphan-resistant AP clusters is that they do not
represent sympathetic C-fibre spiking. We believe this scenario is improbable for three
reasons. First, they likely were not produced by sensory axons sensitive to metabolite
accumulation, stretch, or pain because participants remained still, abstained from exercise
24 hours prior to testing, and did not report any discomfort throughout the protocol.
Second, trimethaphan-resistant APs were unlikely to represent Type I/II proprioceptive
fibre activity, as the myelination of these nerves produces wider APs with prominent
positive-going depolarization (29, 59), which are distinct from the sympathetic C-fibre
APs detected by the wavelet model used here (42). Third, we do not suspect that these
APs represent false positive detections by the wavelet de-noising method because the
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signal-to-noise ratio for these APs in the trimethaphan period was 4.2 ± 0.7, a high level
that produces a false detection rate of < 3 % (42).
Some methodological considerations exist for the present study. First, this study did not
employ a randomized, placebo control arm alongside the trimethaphan condition.
However, in healthy individuals under normal conditions of supine rest, complete
abolishment of MSNA bursts during protracted periods of falling BP would be highly
unlikely. Second, this investigation only studied pre- and post-menopausal females. Both
sex and female reproductive hormones are known to affect resting sympathetic outflow as
well as total MSNA responses to diverse forms of physiological stress (49, 58). However,
these recruitment strategies appear to be fundamental properties of the human
sympathetic nervous system (31, 47) that are simply modified by sex hormones, age
and/or health status (1, 30). Consistent with this notion, the two post-menopausal
participants (participant identifiers TM32 and TM50) exhibited greater baseline MSNA
(due to a burst incidence mechanism rather than the AP content per burst) than premenopausal females (TM32, TM50 vs. pre-menopausal mean ± SD: 44, 46 vs. 24 ± 12
bursts/100beats; 245, 339 vs. 144 ± 80 AP/100beats; 6, 8 vs. 6 ± 2 AP/burst). Despite the
larger effect of trimethaphan on MSNA burst incidence in post-menopausal females
versus pre-menopausal counterparts (D 39, D37 vs. D 15 ± 3 bursts/100 beats, D 231, D
319 vs. D110 ± 51 AP/100beats, D 3, D 5 vs. D 3 ± 1 APs/burst), the ordered pattern of
trimethaphan-mediated AP de-recruitment was consistent between groups (Fig. 2.5A).
Third, Valsalva’s Manoeuvre was used to test adequacy of the blockade based clinically
on heart and BP responses. We recognize that additional manoeuvres before blockade
would have enabled a prospective analysis of reflex AP recruitment as well. Nonetheless,
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Valsalva’s Manoeuvre produces a robust AP recruitment stimulus under baseline
conditions in healthy individuals (44, 50) such that the lack of any recruitment post
blockade indicates a severe impairment of the ganglionic sympathetic transmission.

2.4.1

Conclusion

The current study provides new evidence regarding the role of the paravertebral ganglia
in human MSNA regulation. Specifically, the organization of the ganglia may contribute,
in part, to the distribution of firing probabilities exhibited by differently-sized APs at rest
and the recruitment of previously silent, larger and faster-conducting sympathetic
neurons during homeostatic stress. Interestingly, our observations also suggest that a
population of postganglionic neurons with non-nicotinic synaptic mechanisms may exist
within the human sympathetic nervous system. These findings offer new information
regarding the neural sites which regulate sympathetic emission patterns fundamental to
the maintenance of homeostasis and may contribute to chronic adaptations in sympathetic
discharge in aging and disease.
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Chapter 3

3

Asynchronous action potential discharge in human
muscle sympathetic nerve activity

Published online ahead of print in Am J Physiol Heart Circ Physiol.
doi: 10.1152/ajpheart.00258.2019

3.1 Introduction
The sympathetic nervous system achieves homeostatic adjustments to physiological
stress by eliciting coordinated circulatory responses that are tailored to the magnitude and
form of that stress (31). Microneurographic studies of action potentials (AP) emanating
from postganglionic sympathetic c-fibres directed towards the muscle vasculature have
revealed many fundamental neural patterns for circulatory control (26, 37). The primary
characterization of muscle sympathetic nerve activity (MSNA) focuses on pulse-rhythmic
bursts formed by the synchronized discharge of varying-sized APs entrained to the
cardiac cycle by the arterial baroreflex (9, 16, 38). Among APs synchronized into bursts,
multiple size-related subpopulations exist, expressing non-uniform patterns of discharge
and recruitment that generate the variability in MSNA burst size and occurrence over
time (23, 37).
However, studies in humans (24, 34) and lower mammals (10, 19, 22) suggest that
sympathetic c-fibres may express non-burst forming asynchronous discharge.
Specifically, in healthy humans, we identified a subpopulation of smaller sympathetic
APs active under baseline conditions that persisted to fire when trimethaphan had
abolished integrated bursts. These persistent APs exhibited weak cardiac-rhythmicity,
producing asynchronous discharge (24). In anesthetized cats, both reflex physiological
stress (22) and electrical stimulation of upstream nerves (e.g., hypothalamic or
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preganglionic) (11, 19) produced a rapid burst of synchronized postganglionic nerve
activity followed by asynchronous neural discharge. Interestingly, the initial burst of
synchronous APs was abolished by nicotinic blockade, whereas the asynchronously firing
APs were often blocked by muscarinic antagonists (10, 11, 19, 22), suggesting that nonnicotinic ganglionic mechanisms contribute to asynchronous behaviour. While the
abovementioned evidence points towards asynchronous sympathetic nerve discharge, this
behavior has remained unexplored in humans due to a methodological approach of signal
integration (17) and/or the focus on single- or multi-unit AP activity that occurs within
bursts (36). Studying APs that fire at approximately the same time to form bursts as well
as the APs that express asynchronous behaviour (observed between bursts) in humans
will improve our understanding of sympathetic neural messaging directed towards the
circulation.
Therefore, the present study tested the hypothesis that synchronous and asynchronous
discharge (i.e., APs firing within and between bursts, respectively) exist among human
muscle sympathetic APs, and that the ganglia affect synchronicity within the sympathetic
nervous system. Experiment One quantified AP synchronicity at baseline (BSL) and
during both baroreflex and apneic stress in eight healthy males and females. Experiment
Two examined the impact of nicotinic blockade at the paravertebral ganglia (via
trimethaphan camsylate) on AP synchronicity in a separate sample of healthy female
participants.
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3.2
3.2.1

Methods
Ethical Approval

All procedures were approved by the research ethics boards at the University of Western
Ontario (No. 108026) and Mayo Clinic (No. 09-008548). The study conforms to the
Declaration of Helsinki, except for registration in a database. Participants provided
informed written consent following oral and written explanation of the experimental
procedures and measures.

3.2.2

Participants

Experiment One tested eight healthy individuals (n = 4 females, 26 ± 3 years, 170 ± 7 cm,
69 ± 13 kg), while Experiment Two tested seven healthy females (37 ± 5 years, 165 ± 2
cm, 60 ± 4 kg). Prior to the testing session the participants performed health screening to
ensure they met the inclusion/exclusion criteria: non-smoker and no prior diagnosis of
cardiovascular disease, diabetes, hypertension, or neurological disorder. Experiment One
did not control for oral contraceptive use or stage of menstrual cycle at time of testing. As
reported previously (24), n = 5 females in Experiment Two were pre-menopausal and
tested during the early follicular stage or placebo stage for oral contraceptive users (n = 2,
both taking levonorgestrel and ethinyl estradiol). Participants were not on any other
medications. Two female participants in Experiment Two were post-menopausal (6 and 7
years since last menses).

3.2.3

Experimental Procedures

Participants in Experiment One arrived at the Laboratory for Brain and Heart Health at
the University of Western Ontario for testing after a 4-hour fast and abstaining from

80

vigorous exercise, alcohol, and caffeine for 12-hours prior to the study. Following
measurement of height and weight, participants assumed the supine position for
instrumentation and data collection. Participants were sealed in a lower body negative
pressure (LBNP) chamber distal to the iliac crest. LBNP chamber pressure was measured
with a pressure sensor (MLT0670, ADInstruments; Castle Hill, New South Wales,
Australia) calibrated with a manual sphygmomanometer. A strain gauge (Model 1132
Pneumotrace II, UFI, Morro Bay, CA) enabled investigators to discriminate endexpiratory apnea (APN) from spontaneous breathing. Continuous arterial blood pressure
(BP) was measured via finger photoplethysmography and the Modelflow algorithm (41)
was used to obtain brachial BP, stroke volume, and cardiac output (Finometer; Finapres
Medical Systems, Amsterdam, The Netherlands). Heart rate (HR) was quantified using a
three-lead electrocardiogram (ECG). Participants were familiarized with -40 mmHg
LBNP and at least one APN prior to data collection. Data collection began following at
least 30-min in the supine position. Procedures for Experiment Two, performed in the
Human Integrative Physiology Laboratory at Mayo Clinic (Rochester, MN), have been
described previously (24).

3.2.4

Experimental Design

Experiment One data were collected during: at least 5-min BSL, 3-5 minutes of -10
mmHg LBNP, 3-5 minutes of -40 mmHg LBNP, and APN. Experimental interventions
were performed in a randomized order, though -10 mmHg was always performed before 40 mmHg. Bouts of LBNP and the APN were followed by at least 3-min with the lower
body chamber at ambient pressure prior to the next experimental intervention. Data
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analysis was performed on 190 ± 36 s of BSL, 116 ± 33 s of -10 mmHg LBNP, 109 ± 23
s of -40 mmHg LBNP, and 30 ± 7 s of APN.
Experiment Two data were collected during BSL and a trimethaphan camsylate infusion
(1–7 mg/min; Cambridge Laboratories, Wallsend, UK). These data were obtained
through a retrospective analysis of data reported earlier in an investigation studying the
impact of ganglionic blockade on synchronous AP de-recruitment (24). Here, we focus
on the patterns of asynchronous APs. Trimethaphan infusion rate was adjusted over time,
and variably across participants until ganglionic blockade was achieved. In this study,
ganglionic blockade was defined as participants exhibiting no visible integrated MSNA
bursts and < 5 bpm change in HR from BSL during phase II of Valsalva’s Manoeuvre.
Data analysis was performed on 181 ± 1 s at BSL, the last 86 ± 16 s with visible
integrated bursts during the trimethaphan infusion, and 120 ± 0 s of the trimethaphan
infusion where integrated bursts were not visible. Additional information regarding this
experimental design is available elsewhere (24).

3.2.5

Experimental Measures and Analysis

Continuous postganglionic muscle sympathetic c-fibre discharge was measured by
microneurography at the peroneal nerve using the same equipment and settings in each
experiment (16). MSNA recordings were confirmed by the absence of skin paresthesia
and an increase in bursting discharge upon voluntary APN, but not during arousal to a
loud noise (40). Postganglionic sympathetic activity was recorded with a nerve traffic
analyzer (662C-3; Bioengineering University of Iowa, Iowa City, IA). The neural signal
was pre-amplified with a gain of 1,000 (using preamplifier and isolation amplifier; gains
of 100 and 10, respectively), then further amplified with a gain of 75 (using a variable
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gain amplifier). Neural activity was then band-pass filtered (bandwidth of 700–2,000 Hz)
before being rectified and integrated (using a leaky integrator; 0.1-s time constant). The
filtered and integrated microneurographic signals were sampled at 10,000 Hz while all
other signals were sampled at 1,000 Hz. Data were collected using LabChart 8 and
PowerLab systems (ADInstruments; Castle Hill, New South Wales, Australia) then saved
for offline analysis.
Prior to analysis, integrated and filtered MSNA signals were time adjusted for the
conduction delay, which was derived from the burst latency (see below) of several
varying-sized integrated bursts. Integrated MSNA bursts were included in the analysis if
they aligned with an R-wave and exhibited a 2:1 ratio relative to the previous period of
between-burst signal. Integrated MSNA burst occurrence was quantified as burst
frequency (bursts/min) and burst incidence (bursts/100beats). Burst amplitude (AU) was
measured in volts and normalized to the largest burst at BSL. The product of burst
frequency and normalized amplitude yielded a metric of total MSNA (AU/min). Burst
latency (s) was the time difference between the ECG R-wave and the peak of the
corresponding integrated burst.
In both experiments, muscle sympathetic APs in the filtered neurogram were detected
using a continuous wavelet transform, described in detail previously (32). Throughout all
study conditions any detected APs were extracted, regardless of their temporal coherence
with an integrated MSNA burst. For each condition all extracted APs were ordered based
on peak-to-peak amplitude then assigned to a bin (i.e., cluster) following Scott’s rule
which balances bin width, data bias, and variance to minimize integrated mean square
error (35). Consequently, the number of bins varies across participants and conditions. To
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resolve this, AP bin properties were normalized for each participant to ensure that
minimal bin width (value selected from the condition with the smallest bins), total
number of bins (value selected from the condition with the greatest number of bins), and
maximum bin centre (value selected from the condition with the greatest maximal bin
centre) were identical across conditions. This allowed us to detect whether APs were
recruited or de-recruited from BSL during physiological stress or ganglionic blockade,
respectively, and to compare the behaviour of each cluster between conditions.
Following binning, APs were determined to be firing synchronously or asynchronously
based on the following criteria (Fig. 3.1): An AP was considered to fire synchronously 1)
if its occurrence corresponded with a burst (as defined above) in the integrated MSNA
signal (i.e., within ± 0.4 s of the burst peak), or 2) despite no visible integrated burst, if it
was one of ³ 2 visible APs in the filtered microneurographic signal firing within ± 0.4 s
of an ECG R-wave (after adjusting for the conduction delay). All other APs were
considered to fire asynchronously. For HR > 75 bpm the window for synchronous AP
detection was reduced to one-half the R-R interval. This approach will necessarily
underestimate the occurrence of those asynchronous APs that also occur during a burst
period (either spontaneously or through some synchronization process).
The signal-to-noise ratio (SNR) was determined as the amplitude of the negative peak of
the mean AP over the standard deviation of the background noise around each AP. In
Experiment One the SNR values at BSL (4.0 ± 0.4), -10 mmHg LBNP (4.1 ± 0.4), -40
mmHg LBNP (4.1 ± 0.4), and end-expiratory apnea (4.2 ± 0.5) enabled a correct
detection rate of >95% and a false positive rate of <3% (32). As reported previously (24),
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in Experiment Two the SNR at BSL and the trimethaphan infusion were 4.2 ± 0.7 and 4.2
± 0.5, respectively.
Asynchronous APs were quantified by AP frequency (AP/min) and total AP clusters. The
time between bursts of synchronized APs was used to calculate the asynchronous AP
frequency. Synchronous APs were quantified by AP frequency (AP/min), incidence
(AP/100beats), the number of APs per integrated burst, the number of unique AP clusters
per burst and total AP clusters. For synchronous APs, latency was determined as the time
difference from the R-wave of the preceding cardiac cycle to the negative peak of the AP
(33). Synchronous AP cluster latency was determined as the mean latency of all APs
within a cluster. The relationship between synchronous AP cluster latency and cluster
size was fitted with an exponential decay function. The probability of asynchronous AP
activity (%) was quantified for each AP cluster by taking the number of asynchronous
APs that fired in a given condition divided by the total number of active APs
(asynchronous and synchronous) within each cluster, multiplied by 100%. Distributions
of asynchronous firing across clusters were constructed. The total probability of
asynchronous AP activity (%) was calculated as the number of asynchronously firing APs
regardless of cluster divided by the total number of active APs (asynchronous and
synchronous), multiplied by 100%.

3.2.6

Statistical Analysis

In Experiment One, a repeated-measures analysis of variance (RM ANOVA) assessed the
effect of study conditions (i.e., BSL, -10 mmHg LBNP, -40 mmHg LBNP, and APN) on
AP patterns. For Experiment Two, RM ANOVAs evaluated differences in asynchronous
AP discharge between BSL, the last minute of the trimethaphan infusion, and the period
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of the trimethaphan infusion without visible bursts. For both experiments, post-hoc t-tests
with a Holm-Bonferroni (20) correction were employed for significant RM ANOVAs to
expose which conditions were different from BSL. The relationship between the
probability of asynchronous firing or asynchronous AP frequency and normalized cluster
size was fitted with a logarithmic function. Bland-Altman agreement analysis assessed
the repeatability of asynchronous discharge across different segments at BSL. Statistical
analyses were performed with SPSS Statistics (v 25, IBM Corp., Armonk, NY, USA).
Tests were two tailed with α = 0.05. Data are reported as mean ± standard deviation
unless stated otherwise.

3.3

Results

Experiment One: Quantifying AP synchronicity during baseline, baroreflex, and
apneic stress
Analyses were performed on a total of 607 ± 294 APs (183 ± 99 asynchronous APs), 490
± 260 APs (114 ± 59 asynchronous APs), 753 ± 369 APs (107 ± 67 asynchronous APs),
and 197 ± 79 APs (24 ± 14 asynchronous APs) at BSL, -10 mmHg LBNP, -40 mmHg
LBNP, and APN, respectively in Experiment One.
Compared with BSL, total integrated MSNA increased due to greater burst occurrence in
-10 mmHg LBNP, and due to greater burst occurrence and amplitude during -40 mmHg
LBNP and APN (Table 3.1). Compared to BSL, changes in the integrated measures of
MSNA with -10 mmHg LBNP, -40 mmHg LBNP, and APN were attributed to the
increased occurrence of synchronously firing APs and the number of synchronous APs
per burst. In this study, the total number of synchronously firing AP clusters was
unchanged, but the number of unique AP clusters firing synchronously in bursts was
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increased in all experimental conditions, relative to BSL (Table 3.1). While there was a
main effect of experimental condition (both RM ANOVA P < 0.05) for both integrated
burst and synchronous AP latencies, post-hoc tests revealed no differences on going from
BSL to -10 mmHg LBNP, -40 mmHg LBNP, and APN (Table 3.1). Hemodynamic
variables across conditions are presented in Table 3.1.
At BSL (R2 = 0.42, P < 0.05), -10 mmHg LBNP (R2 = 0.54, P < 0.05), -40 mmHg LBNP
(R2 = 0.74, P < 0.05), and APN (R2 = 0.47, P < 0.05) synchronous AP cluster latency was
related to cluster size, as modelled by an exponential decay function. Consistent with
previous work (37), these data support the concept that the synchronous AP clusters
detected here scaled to the diameter of the sympathetic c-fibres within the
microneurographic recording field.
The representative data from one participant presented in Figure 3.2 demonstrate the
between-burst asynchronous sympathetic AP discharge that exhibited weak cardiacrhythmicity across all experimental conditions. During BSL, 33 ± 12 % of total APs fired
asynchronously. Compared to BSL, the probability of asynchronous AP activity
decreased with -10 mmHg LBNP (26 ± 10 %), -40 mmHg LBNP (15 ± 7 %), and APN
(14 ± 7 %) (Condition Main Effect: P < 0.05; all PPost-hoc < 0.05) (Fig. 3.3). However,
these changes were attributed to greater synchronous discharge (i.e., increased burst
frequency) as asynchronous AP frequency (i.e., APs observed in the absence of bursts)
was not different from BSL (67 ± 37 AP/min) to -10 mmHg LBNP (69 ± 33 AP/min), -40
mmHg LBNP (83 ± 68 AP/min), or APN (62 ± 39 AP/min) (Condition Main Effect: P >
0.05) (Fig. 3.3). Compared to baseline (11 ± 5 clusters), the total number of asynchronous
clusters was similar at -10 mmHg LBNP (12 ± 5 clusters, P Post-hoc > 0.05) and -40 mmHg
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LBNP (12 ± 5 clusters, P Post-hoc > 0.05), but reduced with APN (6 ± 2 clusters; P Post-hoc <
0.05) (Condition Main Effect: P < 0.05). Males and females exhibited similar
asynchronous behaviour across experimental conditions. As depicted in Figure 3.4, when
APs were arranged by peak-to-peak amplitude and clusters were normalized across
conditions, asynchronous APs exhibited similar morphologies to the synchronously firing
APs within the same cluster, across all conditions.
When asynchronous APs were sorted by peak-to-peak amplitude and assigned to 10
normalized clusters, a pattern emerged whereby the asynchronous probability decreased
as a logarithmic function of AP cluster size (i.e., smaller APs were more likely to fire
asynchronously) across all conditions (BSL: R2 = 0.90, P < 0.05; -10 mmHg LBNP: R2 =
0.82, P < 0.05; -40 mmHg LBNP: R2 = 0.74, P < 0.05; APN: R2 = 0.84, P < 0.05) (Fig.
3.5). A similar logarithmic relationship was observed for asynchronous AP frequency.
Examining the size-distribution of normalized AP clusters demonstrated that AP
frequency was consistent for all clusters across the experimental conditions (Fig. 3.5).
Experiment Two: Exploring ganglionic mechanisms contributing to AP
synchronicity
This results section describes the role of the sympathetic paravertebral ganglia in AP
synchronicity. In our previous study (24) examining synchronous AP discharge during
ganglionic blockade, we identified that trimethaphan infusion produced an ordered derecruitment of synchronous APs beginning with the larger APs active at BSL, followed
by reductions in the occurrence of smaller synchronous APs. After several minutes of the
trimethaphan infusion, integrated bursts of MSNA were no longer visible, yet we
recorded a population of smaller, trimethaphan-resistant APs. As reported previously
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(24), HR increased and mean arterial pressure decreased from BSL (57 ± 11 bpm, 97 ± 7
mmHg) to the last minute of trimethaphan with visible bursts (66 ± 12 bpm, 90 ± 7
mmHg) and the period of the trimethaphan infusion where bursts were abolished but
trimethaphan-resistant APs persisted to fire (80 ± 6 bpm, 87 ± 12 mmHg) (Condition
Effect for both HR and BP: P < 0.05, all PPost-hoc < 0.05).
Analyses for Experiment Two were performed on a total of 620 ± 311 APs (148 ± 43
asynchronous APs), 88 ± 52 APs (70 ± 50 asynchronous APs), and 76 ± 63 APs (all APs
were deemed asynchronous) at BSL, the last minute of the trimethaphan condition with
visible bursts, and the period of the trimethaphan condition where bursts had been
abolished, respectively.
As highlighted by one participant’s data in Figure 3.6, the present study tracked and
quantified both synchronous and asynchronous AP discharge from BSL to the last minute
of the trimethaphan condition with visible integrated bursts, and the period of the
trimethaphan infusion where visible bursts had been blocked but a population of smaller
APs persisted to fire asynchronously. In the current analysis, trimethaphan infusion was
associated with de-recruitment of larger asynchronous APs. Compared to BSL (11 ± 4
AP clusters), the total number of asynchronous clusters was reduced in the final minute
of the trimethaphan infusion with visible bursts (7 ± 2 AP clusters), and during the period
of the trimethaphan infusion where bursts were no longer visible (6 ± 2 AP clusters)
(Condition Main Effect P < 0.05; both PPost-hoc < 0.05). Relative to BSL (29 ± 16 %), the
total probability of asynchronous AP firing increased in the final minute of the
trimethaphan infusion with visible bursts (76 ± 13 %; PPost-hoc < 0.05) and further
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increased to 100 ± 0 % (PPost-hoc < 0.05) during the period of the trimethaphan infusion
where smaller APs persisted to fire without visible bursting (Condition Main Effect P <
0.05). However, these changes were attributed to reductions in synchronous AP firing in
bursts with trimethaphan as asynchronous AP frequency did not change from BSL (53 ±
15 AP/min) to the last minute of the trimethaphan infusion with visible bursts (47 ± 23
AP/min), or the period of the trimethaphan infusion without visible bursts [38 ± 31
AP/min; (24)] (Condition Main Effect: P > 0.05).
When asynchronous APs were sorted by peak-to-peak amplitude and assigned to 10
normalized clusters, asynchronous AP probability decreased as a logarithmic function of
cluster size at BSL (R2 = 0.93, P < 0.05) and this relationship was maintained but shifted
upwards for the smaller asynchronous APs continuing to fire during the last minute of the
trimethaphan condition with visible bursts (R2 = 0.70, P < 0.05) (Fig. 3.7). When visible
bursts had been abolished by trimethaphan, the smallest APs that expressed the greatest
asynchronous probability at BSL continued to fire asynchronously without producing
bursts (Fig. 3.7). Trimethaphan de-recruited the largest asynchronous APs but did not
alter the firing rate across the size-distribution of the smaller asynchronous APs (Fig.
3.7).
Repeatability Analysis
Bland-Altman plots (not shown) constructed with data from two BSL periods (BSL
Period One: 199 ± 20 s, BSL Period Two: 176 ± 54 s) from a sub-sample of 8 individuals
(n = 4 participants from Experiment Two; n = 5 females) revealed strong agreement for
the probability of asynchronous APs (BSL Period One: 30 ± 15 %, BSL Period Two: 30
± 13 %; mean difference: 1 ± 5 %, mean absolute difference: 4 ± 3 %) and asynchronous
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AP frequency (BSL Period One: 45 ± 15 AP/min, BSL Period Two: 43 ± 19 AP/min;
mean difference: -1 ± 8 AP/min, mean absolute difference: 6 ± 8 AP/min). For both
variables, all data points fell within two standard deviations of the mean difference.
Neither variable exhibited fixed bias (both P > 0.67). When differences between baseline
periods were regressed against the mean of the baseline periods, asynchronous AP
probability and asynchronous AP frequency did not express proportional bias (both P >
0.14).
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Table 3.1 Hemodynamic, integrated muscle sympathetic nerve activity, and synchronous
sympathetic action potential indices during BSL, -10 mmHg LBNP, -40 mmHg LBNP,
and APN.
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Figure 3.1 Criteria employed to discriminate between synchronous and asynchronous
action potentials (AP) during analysis. Electrocardiogram (ECG), integrated muscle
sympathetic nerve activity (MSNA), filtered MSNA, and detected APs from one
individual. Synchronous AP criterion A: APs were considered to fire synchronously if
their occurrence corresponded with ± 0.4 s from the peak of an integrated MSNA burst.
Synchronous AP criterion B: When no integrated burst was apparent, APs were
considered to fire synchronously if at least 2 APs were visible in the filtered neurogram
and occurred within ± 0.4 s of an ECG R-wave. For HRs ≥ 75 bpm the window for
synchronous APs was reduced to one-half of the R-R interval for that beat. The
neurogram was corrected for the conduction delay. Arrows indicate three APs visible
within the filtered neurogram. APs that did not satisfy these two criteria were deemed
asynchronous. An asterisk (*) indicates the one asynchronous AP detected in this section
of data.
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Figure 3.2 Representative data from one participant depicting the electrocardiogram
(ECG), blood pressure (BP), integrated muscle sympathetic nerve activity (MSNA),
filtered MSNA, and detected action potentials (AP) at baseline (BSL) (A), -10 mmHg
lower body negative pressure (LBNP) (B), -40 mmHg LBNP (C), and the onset of endexpiratory apnea (APN). Data selections illustrate synchronous AP discharge [indicated
by asterisks (*)] often forming bursts and asynchronous APs firing between bursts for
each study condition. Notice in the APN data selection, as indicated by the arrow and
dashed line, that some asynchronous APs fired without cardiac rhythmicity between two
adjacent bursts of synchronous APs. All neurograms were corrected for the conduction
delay.
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Figure 3.3 Probability (A) and frequency (B) of asynchronous action potential (AP)
discharge at BSL (BSL), -10 mmHg lower body negative pressure (LBNP), -40 mmHg
LBNP, and end-expiratory apnea (APN). Mean ± SD for each condition are represented
by filled circles and error bars. Individual data are represented by thin grey lines. P
values for main effect of condition obtained with RM ANOVA are reported. *, indicate
Ppost-hoc < 0.05 vs. BSL.
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Figure 3.4 Representative morphologies of synchronously (left black tracing within each
panel) and asynchronously (right grey tracing within each panel) discharging action
potential (AP) clusters, detected in one participant during BSL (BSL), -10 mmHg lower
body negative pressure (LBNP), -40 mmHg LBNP, and end-expiratory apnea (APN). AP
clusters were binned based on peak-to-peak amplitude. n = 1986 synchronous and n =
454 asynchronous APs fired across all conditions. Thick and thin lines represent means
and standard deviations of cluster amplitude, respectively. Clusters without a mean AP
tracing indicate no AP activity across all study conditions.
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Figure 3.5 Asynchronous AP probability (A) and asynchronous AP frequency (B) versus
normalized AP cluster (normalized to 10 clusters; e.g., cluster 1 represents 0-10% of
largest cluster detected across all conditions) at baseline (BSL), -10 mmHg lower body
negative pressure (LBNP), -40 mmHg LBNP, and end-expiratory apnea (APN). A and B:
Mean ± SE for each cluster are represented by filled circles and error bars. A: data from
each condition were fitted with a logarithmic function.
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Figure 3.6 Representative data from one participant depicting the electrocardiogram
(ECG), blood pressure (BP), integrated muscle sympathetic nerve activity (MSNA),
filtered MSNA, and detected action potentials (AP) at baseline (BSL), the last minute of
the trimethaphan infusion with visible bursts (TM Last Min), and the period of the
trimethaphan infusion with no visible bursts (TM No Burst). Data selections illustrate
synchronous AP discharge [indicated by asterisks (*)] often forming bursts and
asynchronous APs firing between bursts for BSL and TM Last Min and without bursts in
the TM No Burst condition. All neurograms were corrected for the conduction delay.
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Figure 3.7 Asynchronous AP probability (A) and asynchronous AP frequency (B) versus
normalized AP cluster (normalized to 10 clusters; e.g., cluster 1 represents 0-10% of
largest cluster detected across all conditions) at BSL (BSL), the last minute of
trimethaphan with visible bursts (TM Last Min), and the period of the trimethaphan
infusion with no visible bursts (TM No Burst). A and B: Mean ± SE for each cluster are
represented by filled circles and error bars. A: data from BSL and TM Last Min were
fitted with logarithmic functions. No error bars are visible for TM No Burst as all clusters
expressed 100% asynchronous probability (n =7). B: No error bars are visible for the
BSL firing frequency of larger clusters due to small variability (n = 7). Notice that at BSL
all sized APs fired asynchronously but smaller APs expressed the greatest probability of
asynchronous activity. Trimethaphan de-recruited larger asynchronous APs but had no
impact on the overall firing frequency of asynchronous APs.
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3.4

Discussion

The present study provides novel insight to the fundamental behaviour of sympathetic
discharge directed towards the circulation in humans. Specifically, we report
asynchronous AP discharge during periods conventionally thought to represent ‘neural
silence’ between bursts of synchronously firing sympathetic APs. At BSL, asynchronous
AP discharge accounted for approximately 30% of total sympathetic AP activity in each
of two separate experiments where data were obtained from two different laboratories.
Asynchronous AP frequency (measured between bursts) remained constant across
varying degrees of stress. However, the probability of asynchronous APs decreased with
physiological stress due to increased synchronous AP discharge and burst frequency.
Importantly, asynchronous discharge was not uniform across differently-sized APs, as the
probability of asynchronous firing was reduced as cluster size increased. Through
trimethaphan infusion in a group of females, we observed that the trimethaphanresistance property of smaller APs, which we hypothesized earlier (24) to represent nonnicotinic ganglionic mechanisms, contributes to asynchronous discharge of smaller APs
in humans.
Previous investigations employing single- (26) and multi-fibre microneurography (37)
have exposed the fundamental AP patterns contributing to the variability in integrated
burst size and frequency in humans. By studying all active APs in the current analysis,
rather than just those that are found within identified bursts, we observed asynchronous,
between-burst AP activity in healthy individuals and replicated this finding during BSL
conditions in a separate group tested in a different laboratory. To our knowledge, this
study describes the first quantification of synchronicity and report of asynchronous
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discharge within the human sympathetic nervous system. Nonetheless, several studies in
felines have documented asynchronous behaviour in the sympathetic neurogram (10, 11,
19, 22) (discussed in detail below). Asynchronously discharging APs have also appeared
in figures from microneurographic recordings made in humans by multiple laboratories
(25, 30, 34) but have remained unquantified. Of note, in the present study, asynchronous
behaviour was heterogenous, with proportions decreasing logarithmically with increasing
cluster size, in both experiments. This observation aligns with previous evidence
indicating non-uniform discharge, recruitment, and regulation across the size distribution
of recorded APs (33, 34, 38). Asynchronous AP size likely scaled to sympathetic axon
diameter as these APs were similar in morphology to the synchronous APs which
expressed an exponential decay relationship between cluster latency and size. In fact,
this observation suggests that asynchronous APs were also present within the burst
periods. Whether this synchronization process was due to a time-varying synchronization
mechanism, or simply, to random patterns of AP firing, sometimes falling at the time of a
synchronized burst, remains unknown. Unfortunately, our approach to AP detection does
not allow determination of whether the AP clusters that are observed between bursts (i.e.,
asynchronous) and within a burst (i.e., synchronized) arise from the same axon.
The physiological relevance of asynchronous APs remains a compelling question. During
stress (e.g., orthostatic, apneic, chemical, etc.) the sympathetic nervous system increases
the firing rate of previously active synchronous APs and recruits in a synchronized
fashion a subpopulation of previously silent, larger APs increasing integrated burst size
along with burst occurrence (4–7, 27). In contrast, under the conditions of physiological
stress imposed here, the asynchronous APs do not appear to follow the same rules. It is
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clear that bursty patterns of postganglionic sympathetic APs provide the most robust
vasoconstrictor response (2, 3). Therefore, one explanation could be that asynchronous
AP discharge represents an additional sympathetic communication strategy for
maintenance of baseline vasomotor control and have less impact on stress-related
vasoactive outcomes. During times of stress, this subpopulation of asynchronously firing
APs may contribute to vasomotor regulation by firing within bursts through coincidental
capture or some active AP synchronization mechanism. For example, the observation of
unchanged asynchronous firing rate but greater burst frequency on going from BSL to
baroreflex and apneic stress suggests a greater probability of coincidental incorporation
of asynchronous APs in bursts. The finding that fewer asynchronous AP clusters fired
during APN compared to BSL may point towards a stress-specific AP synchronization
process. Both hypotheses represent additional mechanisms for increasing within-burst AP
content during stress, beyond the recruitment of larger axons or increasing the firing rate
of previously active synchronous axons.
Complex neural mechanisms likely govern synchronicity among human muscle
sympathetic c-fibres. Here, in a group of women, we identified that trimethaphan derecruited the largest asynchronously firing APs. However, smaller APs, which expressed
the greatest asynchronous discharge at BSL (and across all conditions in Experiment
One) persisted to fire throughout the trimethaphan infusion, demonstrating resistance to
trimethaphan, as synchronous discharge dissipated. We interpret these data to suggest
that nicotinic ganglionic mechanisms participate in the regulation of synchronous and
asynchronous neuronal discharge and burst production, and that non-nicotinic
mechanisms contribute to the regulation of a subpopulation of small diameter
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asynchronously discharging postganglionic axons. The notion that the ganglia affect the
synchronicity among sympathetic neurons has been tested in cats. These earlier studies
noted that stimulation of preganglionic fibres or hypothalamic nuclei elicited a bimodal
postganglionic response characterized by a rapid-onset synchronous discharge, followed
by a delayed, longer-lasting asynchronous discharge (10, 11, 19). Furthermore, the rapidonset burst of activity to preganglionic stimulation in these experimental models was
consistently abolished by nicotinic receptor antagonists, whereas muscarinic antagonists
eliminated asynchronous firing (10, 11, 19, 22). In canines, a nicotinic-muscarinic
interaction mediated the firing of a discrete subpopulation of postganglionic
vasoconstrictor fibres that were activated by chemical stress and resistant to nicotinic
blockade (18). Peptidergic and purinergic ganglionic co-transmission may also contribute
to asynchronous AP firing (14, 21).
Additional factors beyond ganglionic mechanisms may contribute to asynchronous AP
discharge. We base this conjecture on the finding that asynchronous firing was observed
across all AP clusters, not just the smaller APs expressing trimethaphan-resistance. One
possibility is the baroreflex effect that exerts considerable influence over the cardiacgated bursty pattern of MSNA (12, 29). Our previous study examining only
synchronously firing APs revealed that small-to-moderate sized APs received
considerable baroreflex influence whereas the larger APs did not (34). This may be
attributed to sympathetic neurons projecting directly from supra-medullary sites (e.g.,
paraventricular hypothalamus or pons) to spinal neurons, as documented in rats (39).
Specifically, the current analysis revealed that asynchronous APs did not always exhibit
cardiac rhythmicity and asynchronous AP frequency remained constant in both
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experiments across a range of HRs and BPs, suggesting that features of baroreflex or
cardiac afferent inputs do not modulate completely this population of sympathetic
neurons. Also, the rhythmicity – due to intrinsic pacemaker behaviour and/or neural
inputs – of extra-baroreflex supra-medullary and spinal nuclei likely exert additional
control over AP synchronization, but how these sites interact with the baroreflex to shape
postganglionic discharge requires investigation (1, 8, 15, 28). Combined, our two
experiments suggest that compared to synchronously discharging axons, the
postganglionic c-fibres generating asynchronous APs are governed differently at the
central and/or peripheral level of the sympathetic organization.
We are confident that all APs reflected sympathetic postganglionic axonal firing for the
following reasons. First, the continuous wavelet technique used here extracts APs
matching real human muscle sympathetic APs (32). Inspection of all extracted AP
clusters revealed the prototypical extracellular sympathetic c-fibre morphology as
obtained by the hardware and signal processing employed by our laboratory (38) and
others (13). Second, the microneurographic recordings were made from muscle
sympathetic bundles only, as in each participant the neural signal expressed spontaneous
pulse-rhythmic bursting that increased during apnea but not with arousal to a loud noise
or when stroking the skin (16). Third, based on the high-quality nerve recordings our AP
detection software operates with a false detection rate of less than 3% (32). While the
possibility remains, the abovementioned lines of evidence minimize the likelihood that
our analysis included sympathetic APs other than those originating from muscle
sympathetic nerves.
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3.4.1

Conclusion

This study advances our knowledge of the sympathetic neural communication strategies
contributing to circulatory regulation. Particularly, we identified that asynchronous AP
discharge, rather than complete ‘neural silence’, exists between bursts of synchronously
firing sympathetic APs, and the degree of asynchronous discharge scales inversely to AP
size, such that smaller APs express the greatest probability of asynchronous firing. Thus,
approaches to MSNA quantification that rely on signal integration (16), or focusing on
within-burst AP discharge using single- (27) or multi-unit (38) techniques, appear to
underestimate and conceal a fundamental element of muscle sympathetic AP discharge.
During a physiological challenge, the inclusion of previously asynchronous APs into
bursts may represent an additional strategy to increase burst size. Based on patterns of AP
behaviour during the trimethaphan infusion, we propose that non-nicotinic receptors at
the ganglia underlie asynchronous behaviour, at least for the smaller AP clusters.
However, central sympathetic mechanisms such as reduced baroreflex control of discrete
AP subpopulations may also generate asynchronous firing. The current findings represent
an additional layer of intricacy contained within the neural language of the sympathetic
nervous system as well as a component of the neural organization subserving this
communication strategy.
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Chapter 4

4

Baroreflex control of sympathetic action potential
subpopulations during orthostatic stress

4.1

Introduction

Pulse-rhythmic feedback from arterial baroreceptors synchronizes action potential (AP)
discharge to produce the characteristic bursty pattern of muscle sympathetic nerve
activity (MSNA) (5, 7, 35). While the baroreflex imposes strong regulation over the
frequency of these bursts, burst amplitude –– a function of the size and number of
synchronously firing APs –– exhibits only weak baroreflex control (14, 24, 37). This
stems from the baroreflex exerting differential control over the varying-sized sympathetic
APs (representing different sized axons) synchronized to fire in bursts (31). Specifically,
under baseline conditions, the arterial baroreflex strongly governs medium-sized APs,
which fire in most bursts, but minimally governs larger AP clusters, which fire with low
probability and contribute proportionately more to larger bursts (31, 35). Also, small APs
may not be governed strongly by the arterial baroreflex. In fact, we reported that 30% of
total APs fired asynchronously outside baroreflex-gated bursts at baseline, with smaller
APs expressing the greatest proportion of asynchronous discharge (17).
Arterial baroreflex-mediated sympathetic arousal represents a critical mechanism for
blood pressure regulation during orthostatic stress (8, 33). Unlike other forms of stress
(e.g., chemical, metabolic, or apneic) (15, 20, 34), baroreflex unloading represents a weak
reflex when it comes to recruiting larger, latent AP clusters (i.e., high-threshold axons)
until severe levels, such as -80 mmHg lower body negative pressure (LBNP), with some
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inter-individual variability (2, 29). Thus, the baroreflex relies primarily on increasing the
firing probability of previously-active APs (i.e., low-threshold axons) to elicit
sympathoexcitation during orthostatic stress (29). Yet, the precise mechanisms
subserving the enhanced firing rate remain unclear. Based on the observation that
medium AP clusters express strong baroreflex regulation under baseline conditions (31)
we reasoned that the upward shift in baroreflex control over integrated bursts of MSNA
during orthostatic stress (11, 12, 29) might be related to specific control over these
medium AP clusters along with relocation of the operating points to positions of greater
gain to facilitate enhanced discharge. However, observations made during the
hypotensive phase of a modified Oxford test of reduced firing probability of the cluster of
the smallest APs (18) suggest that this subpopulation may express reductions in
baroreflex control during orthostatic stress.
Therefore, this study aimed to examine the heterogeneity of baroreflex control over AP
discharge by measuring the baroreflex gain of all AP clusters. This research tested the
hypothesis that during orthostatic stress the baroreflex confers its greatest effect on the
gain of medium AP clusters that fire normally with high probability. If so, then the
change in position and slope of each AP cluster’s baroreflex curve should vary across the
distribution of recorded APs.

4.2
4.2.1

Methods
Ethical Approval

This study received approval from the Health Sciences Research Ethics Board at the
University of Western Ontario (No. 108026). This study conforms to the Declaration of
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Helsinki, except for registration in a database. Each participant provided informed written
consent to the study following verbal and written explanations of study procedures

4.2.2

Sample

Six healthy young individuals (3 females) participated in this study (26 ± 1 years, 170 ± 2
cm, 70 ± 6 kg). Participants were normotensive and were free of cardiovascular or
neurological disease. This study did not control for oral contraceptive use or stage of the
menstrual cycle in females (39).

4.2.3

Experimental Procedures and Protocol.

Participants arrived at the Laboratory for Brain and Heart Health at the University of
Western Ontario after a 4-hr fast and avoiding alcohol and caffeine consumption, and
vigorous physical exercise for 12 hours. Participants were instructed to empty their
bladder after which they assumed the supine position with their lower body sealed below
the iliac crest in a LBNP chamber for the duration of the study. Participants were
familiarized with a bout of LBNP prior to commencing the experimental protocol.
Data collection began following at least 30 minutes in the supine position. The
experimental protocol consisted of: 1) at least 5 minutes under baseline (BSL) conditions,
2) 3 – 5 mins exposure to -40 mmHg LBNP, and 3) 3 – 5 mins exposure to -80 mmHg.
The order of tests was not randomized or varied due to the greater risk of signal loss at
the higher level of lower body suction. The maximal LBNP level that provided high
quality microneurographic data was analyzed for each participant. LBNP -40 mmHg was
used for two participants (1 female) and LBNP -80 was used for four participants. Similar
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changes in baroreflex gain were observed on going from BSL to either -40 mmHg or -80
mmHg LBNP so these levels were collapsed into a single LBNP condition.

4.2.4

Experimental Measures and Analysis.

A 3-lead ECG measured heart rate (BioAmp FE132, ADInstruments; Bella Vista, New
South Wales, Australia). Beat-by-beat blood pressure was measured by finger
photoplethysmography (Finometer; Finapres Medical Systems, Amsterdam, The
Netherlands) with the Modelflow algorithm providing stroke volume and cardiac output
(40). Reconstructed brachial blood pressures were calculated and used for analysis. Total
peripheral resistance was calculated as the quotient of mean arterial pressure and cardiac
output. A calibrated pressure sensor measured chamber pressure (MLT0670,
ADInstruments; Castle Hill, New South Wales, Australia).
Continuous muscle sympathetic postganglionic c-fibre discharge was measured from the
common peroneal nerve as described originally by Hagbarth and Vallbo (9), and recently
by our laboratory (16, 17). Postganglionic sympathetic activity was recorded with a nerve
traffic analyzer (662C-3; Bioengineering University of Iowa, Iowa City, IA). The neural
signal was pre-amplified with a gain of 1,000 (using preamplifier and isolation amplifier;
gains of 100 and 10, respectively), then further amplified with a gain of 75 (using a
variable gain amplifier). Neural activity was then band-pass filtered (bandwidth of 700–
2,000 Hz) before being rectified and integrated (using a leaky integrator; 0.1-s time
constant). Muscle sympathetic nerve activity (MSNA) was confirmed by the absence of
skin paresthesia and the observation of an increase in bursting during a volitional apnea,
but not arousal to a loud noise. Filtered and integrated MSNA signals were sampled at
10,000 Hz, while all other signals were sampled at 1,000 Hz. LabChart 8 and PowerLab
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systems (ADInstruments; Bella Vista, New South Wales, Australia) enabled data
collection, storage, and analysis.
Integrated MSNA bursts were analyzed if they aligned with an R-wave and exhibited a
2:1 ratio relative to the previous period of between-burst signal. Burst frequency
(bursts/min), burst incidence (bursts/100beats), and burst amplitude (AU) normalized to
the largest burst at BSL, provided metrics of the integrated MSNA.
As described previously (28), sympathetic APs were extracted from the filtered
neurogram using a continuous wavelet transform. Based on our previous finding that a
considerable amount of AP discharge occurs asynchronously between bursts (17), any AP
that was detected during BSL and LBNP was extracted regardless of whether or not it
occurred within an identified burst of MSNA. APs were ordered based on peak-to-peak
amplitude and sorted into bins (i.e., clusters) using Scott’s rule. Within each participant,
AP bin properties were normalized to ensure that bin width, bin number, and maximum
bin centre were identical between BSL and LBNP. This strategy enables quantification of
the number of AP clusters that were recruited from BSL to LBNP and the change in
firing probability for each cluster. Moreover, to enable between-participant comparisons
of AP cluster activity, data were normalized to the largest AP cluster (which fired during
LBNP in all participants) and assigned to 15 clusters. The signal-to-noise ratio (SNR)
was determined as the amplitude of the negative peak of the mean AP over the standard
deviation of the background noise around each AP at BSL (3.9 ± 0.1) and LBNP (4.1 ±
0.1). These values of SNR will ensure a correct detection rate of ~95% and a false
positive rate of <3% (28).
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During each condition, AP behaviour was quantified by AP frequency (AP/min),
incidence (AP/100beats), and the total number of AP clusters (total bins). In heartbeats
with AP discharge, AP behaviour was also quantified by the number of APs per heartbeat
(spikes/beat) and the number of unique clusters per heartbeat (bins/beat). The firing
probability (%) of each cluster was calculated as the quotient of the total number of times
each cluster fired and the total number of heartbeats, multiplied by 100%.

4.2.5

Integrated baroreflex threshold and sensitivity

For both experimental conditions, baroreflex threshold and sensitivity analyses were
performed for integrated bursts and AP clusters following the nomenclature employed
previously (10, 14, 31). Baroreflex threshold analysis for integrated bursts involved
grouping the diastolic blood pressures (DBP) of individual heartbeats into 2-mmHg bins
and calculating the burst probability (%) for each DBP bin: that is, the percentage (%) of
heartbeats per DBP bin that were associated with an integrated burst. Integrated
baroreflex threshold gain for burst occurrence was measured as the slope of the linear
relationship between burst probability versus the mean DBP for each bin. Baroreflex
sensitivity gain for integrated burst size was measured as the slope of the relationship
between individual normalized burst amplitude versus the corresponding DBP. For all
regressions, Pearson’s correlation coefficients were recorded. For both experimental
conditions, the operating point was determined for integrated baroreflex threshold and
sensitivity diagrams by plotting the point of intersection of mean burst probability or
amplitude, respectively, and mean DBP.
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4.2.6

Action potential baroreflex threshold and sensitivity

Baroreflex threshold analysis for AP occurrence was performed for each AP cluster based
on a previously described method (31). Consistent with above, DBPs were grouped into
2-mmHg bins and AP probability (%) for each bin was calculated. For each cluster,
baroreflex threshold gain was measured as the slope of the linear relationship between
AP probability versus the mean DBP for each bin. AP baroreflex sensitivity gain was
calculated as the slope of the linear relationship between the number of unique AP
clusters that fired in each heartbeat versus the DBP for that beat. Pearson’s correlation
coefficients were recorded for each regression. For both experimental conditions, the
operating point was determined for AP cluster baroreflex threshold diagrams by plotting
the point of intersection for mean cluster probability and mean DBP. The operating point
for AP baroreflex sensitivity was determined by plotting the point of intersection for the
mean number of unique AP clusters per heartbeat and the mean DBP.

4.2.7

Statistical Analysis

A two-way repeated measures analysis of variance (RM ANOVA) assessed the impact of
experimental condition and AP cluster on the slope of the AP level baroreflex threshold
relationship. Main effects (i.e., condition, AP cluster) and interactions (i.e., condition-byAP cluster) were tested. Hypothesis-driven planned contrasts were executed using onetailed paired t-tests to inspect significant interactions. Paired sample t-tests examined the
impact of condition on hemodynamic, integrated burst and AP indices, and baroreflex
variables. Values are mean ± SE. Tests were two-tailed unless otherwise specified, with
a = 0.05. Statistical analyses were performed with SPSS Statistics (v 25, IBM Corp.,
Armonk, NY, USA).
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4.3

Results

Fig. 4.1 depicts the representative hemodynamic and sympathetic neural emissions at
BSL and LBNP. Compared to baseline, burst occurrence and amplitude increased with
LBNP (Table 4.1). Augmented integrated bursting behaviour during LBNP was
associated with an increase in AP occurrence and AP content per heartbeat compared to
BSL, which was attributed to an increase in the firing probability of previously active
APs and the recruitment of larger latent APs (Table 4.1). Fig 4.2 illustrates AP discharge
by cluster over time as a function of DBP in a single individual at BSL and LBNP. A
total of 254 ± 22 s of data were analyzed at BSL and 182 ± 22 s during LBNP.
Fig. 4.3 illustrates the mean regression outcomes calculated for the baroreflex threshold
and sensitivity diagrams for integrated sympathetic bursts during BSL and LBNP. Under
BSL conditions, the baroreflex strongly regulated burst occurrence [slope (b): - 3.8 ± 0.4
%/mmHg, y-intercept (y-int): 302 ± 31 %, r = -0.89 ± 0.03], but exhibited weaker control
(P value for b comparison: < 0.05) over normalized burst amplitude (b: -1.4 ± 0.4
AU/mmHg, y-int: 144 ± 29 AU, r = -0.21± 0.1). Compared to BSL, neither the slope of
the baroreflex threshold (b: -4.1 ± 0.8 %/mmHg, y-int: 357 ± 75 %, r = 0.89 ± 0.02) or
sensitivity (b: -0.7 ± 0.5 AU/mmHg, y-int: 125 ± 38 AU, r = - 0.04 ± 0.1) relationships
were altered with LBNP (both P > 0.05). However, the operating points for both
baroreflex threshold [BSL (DBP, probability): 71 ± 3 mmHg, 31 ± 3 %; LBNP (DBP,
probability): 75 ± 2 mmHg, 51 ± 4 %] and sensitivity relationships [BSL (DBP,
normalized amplitude): 71 ± 3 mmHg, 44 ± 3 AU; LBNP (DBP, normalized amplitude):
75 ± 2 mmHg, 73 ± 8 AU] were reset rightwards (P < 0.05) and upwards (P < 0.05) from
BSL to LBNP.
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Fig. 4.4 shows the mean baroreflex threshold relationships calculated for 15 normalized
clusters at BSL and LBNP. At BSL, the strength of baroreflex control over AP
occurrence varied by AP size, such that medium APs expressed the greatest threshold
slopes, while the smallest (BSL normalized cluster 3 vs. BSL normalized cluster 1: P <
0.05) and largest (BSL normalized cluster 3 vs. BSL normalized cluster 7: P < 0.05)
active clusters exhibited lesser threshold slopes. The change in baroreflex threshold slope
from BSL to LBNP varied by AP cluster size (Condition: P < 0.05, Cluster: P < 0.05,
Condition-by-Cluster: P < 0.05). Specifically, medium AP slopes increased with LBNP,
while the slopes for the smallest and largest APs present at BSL exhibited a reduction and
no change respectively, compared to BSL. The larger AP clusters which were silent at
BSL and recruited with LBNP fired with low probabilities at LBNP and expressed weak
baroreflex threshold slopes (LBNP normalized cluster 4 vs. LBNP normalized cluster 14:
P < 0.05). Fig. 4.5 illustrates the interactive effects of condition and cluster on the slope
of AP baroreflex threshold relationship. At BSL and LBNP, the mean Pearson’s
correlation statistics for the threshold relationships were stronger than r = - 0.50 for all
normalized clusters, with the exception of cluster 1 (r = -0.49 ± 0.10), cluster 2 (r = -0.36
± 0.10), and cluster 15 (r = -0.45 ± 0.13) firing during LBNP. Males and females
expressed similar changes in baroreflex control of AP discharge from BSL to LBNP.
Inspection of operating points by cluster (Fig. 4.4) demonstrated that the AP clusters
expressed non-uniform firing probabilities, where the medium APs exhibited the greatest
probabilities and the smallest (BSL normalized cluster 3 vs. BSL normalized cluster 1: P
< 0.05) and largest APs (BSL normalized cluster 3 vs. BSL normalized cluster 7: P <
0.05) present at BSL fired less often. The operating points of medium clusters (e.g.,
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normalized clusters 3 to 8) were reset upwards (P < 0.05) and rightwards with LBNP (P
< 0.05), while the operating points of smaller and larger clusters active at BSL were only
shifted rightwards (Condition: P < 0.05, Cluster: P < 0.05, Condition-by-Cluster: P <
0.05).
Last, Fig. 4.6 highlights the mean baroreflex sensitivity relationships for AP cluster
behaviour at BSL (b: -0.12 ± 0.03 AP clusters/beat/mmHg, y-int: 12 ± 3 AP
clusters/beat) and LBNP (b: -0.22 ± 0.1 AP clusters/beat/mmHg, y-int: 21 ± 4 AP
clusters/beat). A weak slope was observed for the baroreflex sensitivity relationship at
BSL and was unchanged, but the operating point was reset rightwards (P < 0.05) and
upwards (P < 0.05) with LBNP [BSL (DBP, AP clusters/beat): 71 ± 3 mmHg, 3 ± 0.3 AP
clusters/beat; LBNP (DBP, AP clusters/beat): 75 ± 2 mmHg, 5 ± 1 AP clusters/beat].
Weak Pearson correlation coefficients were observed for the AP cluster baroreflex
sensitivity relationships under both conditions (BSL: r = - 0.25 ± 0.1, LBNP: r = - 0.37 ±
0.1).
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Table 4.1 Hemodynamic variables, integrated, and action potential level indices of
muscle sympathetic nerve activity at baseline and lower body negative pressure.
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Figure 4.1 Data from a single individual illustrating hemodynamic data, integrated
muscle sympathetic nerve activity (MSNA) and filtered MSNA at baseline (BSL) and
lower body negative pressure (LBNP; -80 mmHg in this example).
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Figure 4.2 Data from a single individual illustrating the pattern of action potential (AP)
discharge over time as a function of their diastolic blood pressure (DBP; top) and cluster
(left) at baseline (BSL) (A) and lower body negative pressure (LBNP; -80 mmHg in this
example) (B). AP cluster refers to all APs of similar morphology and are normalized
between conditions to ensure within-participant comparisons (e.g., cluster 1 represents
the same-sized APs at BSL and LBNP). (Previous page).
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Figure 4.3 Mean baroreflex threshold relationships for the integrated muscle sympathetic
nerve activity (MSNA) burst occurrence (A) and mean baroreflex sensitivity relationships
for normalized integrated MSNA burst size at baseline (BSL) and lower body negative
pressure (LBNP) (B). Filled and empty circles with error bars (SE) represent the
operating points at BSL and LBNP, respectively.
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Figure 4.4 Mean baroreflex threshold relationships between action potential (AP)
discharge probability and diastolic blood pressure (DBP) for 15 normalized clusters at
baseline (BSL) and lower body negative pressure (LBNP). Filled and open circles with
error bars (SE) represent the operating point for each cluster at BSL and LBNP,
respectively.
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Figure 4.5 Mean baroreflex threshold slopes for 15 normalized action potential (AP)
clusters at baseline (BSL) and lower body negative pressure (LBNP). Means and SE are
presented. This figure represents the slopes of the baroreflex threshold relationships
depicted in Fig. 4. *, indicates P < 0.05 (one-tailed, planned contrast).
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Figure 4.6 Mean baroreflex sensitivity relationship between the number of action
potential (AP) clusters per beat and diastolic blood pressure (DBP) at baseline (BSL) and
lower body negative pressure (LBNP). Filled and open circles with error bars (SE)
represent the operating point at BSL and LBNP.
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4.4

Discussion

The present study exposed new knowledge regarding the baroreflex mechanisms
contributing to elevated sympathetic AP discharge during orthostatic stress. First, we
identified that the baroreflex gain for APs active at BSL becomes modified during LBNP.
However, LBNP-mediated modifications to baroreflex gain varied by AP cluster size
such that the slopes for medium-sized APs increased with LBNP, while the slopes for the
smallest and largest APs active at BSL exhibited a reduction and no change, respectively,
compared to BSL. Also, new and larger APs that were silent at BSL and recruited with
LBNP expressed weak baroreflex control. Examining baroreflex control of MSNA using
integrated measures concealed the impact of LBNP as the strength of baroreflex control
over burst occurrence and burst size was unchanged from BSL to LBNP. We interpret
these findings to suggest that when defending blood pressure during orthostatic stress,
baroreflex control of a discrete group of medium-sized sympathetic APs active at
baseline becomes enhanced concurrent with an increase in firing rate. Also, the findings
suggest further that the recruitment process that leads to the appearance of larger AP
clusters during LBNP that were not present at baseline, is not due to a baroreflex
mechanism.
In the present study, a collection of medium clusters (e.g., normalized clusters 4 to 8)
exhibited augmented baroreflex gain concomitant with a relocation of the baroreflex
slopes to greater firing probabilities and elevated DBP from BSL to LBNP. Some of
these AP clusters expressed strong baroreflex slopes and fired with high probabilities at
BSL (i.e., normalized clusters 4 and 5). This observation replicates findings from our
previous investigation with a different group of participants (31). Of note, however, both
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the gain and operating point of these high probability AP clusters were reset during
LBNP. Thus, it appears that the baroreflex strongly controls the behaviour of most
medium APs. Fundamentally, enhanced baroreflex control during LBNP enables greater
inhibitory control to prevent exaggerated sympathetic arousal during orthostatic stress
(41) but also greater AP firing for a given change in DBP.
Unlike medium AP clusters, the largest AP clusters active during BSL expressed weak
baroreflex control that was unchanged with LBNP (i.e., normalized clusters 9 to 13).
Whether greater levels of baroreflex stress than those imposed here could have
augmented the baroreflex gain for these APs remains to be tested but we suspect that the
likelihood remains low as these APs appear to be governed primarily by other neural
inputs (1, 35). Similarly, we found the largest APs that were previously silent at BSL and
recruited during LBNP express weak baroreflex slopes in all participants (i.e., normalized
clusters 14 and 15). This finding aligns with our previous observation that this AP
subpopulation was only recruited during severe levels of baroreflex stress (29). Here,
even during baroreflex stimuli sufficient for recruitment, the baroreflex only weakly
governed the moment-to-moment discharge of these APs. We suspect that either a
threshold of baroreflex unloading must be reached to withdraw baroreflex-inhibition over
the central neural region(s) primarily governing this subpopulation or some other nonbaroreflex mechanism recruited these APs. Indeed, many forms of physiological stress
recruit previously silent larger and faster conducting APs including those activating the
arterial chemoreflex and muscle metaboreflex along with manoeuvres involving
volitional effort or perceptual stress (e.g., Valsalva’s Manoeuvre, voluntary apnea) (1, 15,
30, 32, 34, 35). In these other manoeuvres, it remains possible that baroreflex resetting is
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responsible for the recruitment of previously silent APs. However, the current data argue
against that mechanism. Rather, the present results support the hypothesis that large AP
clusters, including those firing infrequently at BSL and the subpopulation of latent, highthreshold APs receive a variety of neural inputs, but baroreflex afferents do not represent
the dominant source (19, 22). The organization of baroreflex inputs within medullary
brainstem nuclei and/or direct projections from supra-medullary sites (e.g.,
paraventricular nucleus of the hypothalamus, caudal raphe nuclei, pons) to spinal
preganglionic neurons may contribute to reduced baroreflex control of larger sympathetic
axons (4, 21, 36).
In the current study, the cluster of the smallest APs (i.e., normalized cluster 1) expressed
intriguing baroreflex control. In the BSL condition, the small APs demonstrated lesser
baroreflex gain compared to medium-sized clusters. Previously our laboratory reported
reduced baroreflex control as AP size increased, yet individual data figures presented in
this earlier study do hint at the BSL behaviour illustrated here (31). This pattern was
likely exposed more clearly in the present study by cluster normalization and because we
extracted all detected APs regardless of if they fired within or between bursts, whereas
our previous study focused solely on the synchronized APs forming integrated bursts
(31). This analysis strategy was based on a recent observation that about 30% of
sympathetic APs at BSL fire asynchronously between MSNA bursts in healthy young
individuals, with the smallest APs expressing the greatest proportion of asynchronous
activity (17). While we did not examine the baroreflex gain of synchronous and
asynchronous APs separately here, reduced baroreflex control of small APs may
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represent an additional mechanism contributing to asynchronous behaviour of this
subpopulation in our previous study.
Compared to BSL, the cluster of the smallest APs (e.g., normalized cluster 1) showed
reductions in baroreflex gain but no change in firing probability during LBNP, pointing
to diminished baroreflex regulation during orthostatic stress. No previous study has
investigated baroreflex control of AP occurrence during physiological stress, but some
insight may be gained from earlier investigations of multi-unit AP discharge during
baroreflex stress. Using the wavelet approach to extract APs firing within bursts, Limberg
and colleagues (18) observed a paradoxical reduction in the smallest AP cluster firing
probability during orthostatic stress imposed by sodium nitroprusside infusion. Also, the
single-unit technique has exposed a subpopulation of APs that display paradoxical
reductions in firing frequency during modest LBNP (13, 23). Overall, these data indicate
that the small APs are regulated primarily by non-baroreflex processes and/or may be
inhibited by baroreflex unloading.
The mechanisms underlying modifications in baroreflex control across the size-range of
AP subpopulations remain unclear. Baroreflex slopes were calculated from spontaneous
pressure fluctuations that were not large enough to estimate the complete baroreflex
sigmoid for the various AP clusters this study. While the baroreflex sigmoid relationship
(6, 27) remains to be derived for sympathetic discharge at the AP level, we speculate that
for medium AP clusters, the baroreflex functions are shifted to higher levels of activity
and greater DBPs, and that the operating points relocate to regions of greater gain during
orthostatic stress. Based on the variability in baroreflex slope and operating point among
medium clusters at BSL and LBNP, we hypothesize that of the medium-sized APs under
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strong baroreflex control, the position of the operating point and/or morphology of the
baroreflex sigmoid may depend on AP size. The alterations in baroreflex function from
BSL to LBNP observed here may be linked to reductions in pulse pressure detected by
arterial baroreceptors, or relocation of venous blood detected by cardiopulmonary
baroreceptors and/or venous mechanoreceptors (3, 25). Also, descending neural signals
related to the perception of effort accompanying the muscular contraction required to
resist suction during LBNP may have shaped baroreflex behaviour in this study (26).
Historically, baroreflex control of MSNA has been quantified by relying on the integrated
signal to examine the relationship between burst occurrence or burst size and DBP (14,
38). In the present study, we replicated findings from our laboratory and others indicating
that under BSL conditions, the arterial baroreflex strongly governs burst occurrence and
only weakly controls burst size (12, 14, 20, 31). Consistent with previous research (11,
12), we observed no change in the strength of baroreflex control over integrated burst
probability or burst size from BSL to LBNP, but the operating points were shifted to
higher levels of activity and greater DBP. The finding that LBNP did not impact the weak
baroreflex regulation of burst size can be explained by the following: 1) Burst size is a
function of the number and size of APs, with larger APs contributing mainly to larger
bursts (35), and 2) LBNP did not impact the strength of baroreflex control over the
number of unique clusters per beat or the occurrence of the largest APs. Why baroreflex
control of integrated burst occurrence remained unchanged from BSL to LBNP despite
enhanced baro-control of medium APs (which fire in most bursts) remains unclear. Only
the upward and rightward shifts in medium AP operating points were mirrored in the
integrated baroreflex threshold operating point. Perhaps the heterogeneous changes in
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baroreflex control of differently AP subpopulations rendered the slope of the integrated
baroreflex threshold relationship unchanged due to the averaging impact of the
integration process.

4.4.1

Conclusion

The present study discovered that the baroreflex gain of the subpopulation of mediumsized sympathetic APs that were active under BSL conditions becomes enhanced and
reset to higher levels of activity to facilitate elevated sympathetic discharge during
LBNP. The large APs present under BSL conditions and the subpopulation of larger APs
that were silent at BSL but recruited during LBNP were under weak, if any, baroreflex
control. Clusters of small APs, which express weak baroreflex control under baseline
conditions exhibit paradoxical reductions in gain during LBNP. Also, the baroreflex
expressed minimal control over the number of unique AP clusters firing per beat under
both conditions. Thus, baroreflex control represents only one input to sympathetic
activation during orthostatic stress. Baroreflex control appears to form a modifiable
mechanism –– at least for a discrete subpopulation of medium-sized APs –– enabling
precise regulation of sympathetic outflow during orthostatic stress in healthy young
individuals.
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Chapter 5

5

General Discussion

The studies comprising the present dissertation provide new knowledge regarding the
behaviour of, and mechanisms governing, low-threshold sympathetic APs: APs that are
active during baseline conditions and some of which exhibit augmented firing during
physiological stress. We illustrated that sympathetic c-fibre discharge results from the
integration of arterial baroreflex and yet unknown non-baroreflex inputs within the
central sympathetic circuitry, and contributions from the paravertebral ganglia, where
interactions between nicotinic and non-nicotinic neurotransmission along with varying
patterns of pre-to-postganglionic innervation exist. Consequently, low-threshold APs do
not express uniform behaviour, but rather function as discrete subpopulations related to
postganglionic AP size (reflecting different sized axons) that receive differential
regulation and express varying firing properties, during baseline conditions and
physiological stress. Consistently, the discharge probability among low-threshold APs
relates to AP cluster size in a manner that resembles an inverted “U” distribution.
Collectively, the data generated by these studies indicate that the subpopulation of
medium APs fires synchronously within most bursts of MSNA [Study One (10), Study
Two (11), and Study Three] as a result of upstream neurons linked to this postganglionic
subpopulation receiving strong baroreflex regulation (Study Three) and predominantly
nicotinic mechanisms at the ganglia (Study One). During baroreflex stress imposed by
mild to severe LBNP, the firing probability of medium APs becomes increased (i.e., ratecoding mechanism) as a result of an upward resetting in the baroreflex control and
relocation of the operating point to a position of enhanced gain (Study Three). It should
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be noted however, that even within the subpopulation of medium APs under baroreflex
control some variability exists in baseline firing probabilities, baroreflex gain, and the
responses to baroreflex stress, which we hypothesize stems from baroreflex sigmoid
morphology and characteristics (e.g., operating point location) varying by AP size (21).
Based on these observations we suspect that this subpopulation of APs aligns with those
recorded using the single-unit technique, particularly the seminal investigations by
Macefield and colleagues (15, 16). These studies observed most APs to fire once per
burst during periods of baroreceptor unloading accompanying transient reductions in
blood pressure under baseline conditions and express the capacity to increase firing
probability during physiological stress (15, 16). Also, the consistent finding that
integrated bursts are abolished by trimethaphan (1, 2, 5) aligns with the conclusion that
medium APs contribute to most bursts and are primarily governed by nicotinic ganglionic
neurotransmission.
Combined, the present findings suggest that the regulatory mechanisms governing the
subpopulation of small sympathetic APs are fundamentally different than those regulating
medium APs, both within the central circuitry and at the ganglia. This dissertation
highlights that non-baroreflex mechanisms form the primary input to the upstream nerves
linked to this subpopulation of smaller APs. For example, under baseline conditions, the
small APs expressed low firing probabilities (Study One) and when we examined all APs
rather than just those within integrated bursts, this subpopulation exhibited the greatest
proportion of asynchronous discharge, indicating that their firing was not initiated in
diastole or terminated in systole by baroreflex mechanisms (Study Two). Also, the
clusters of the small APs did not respond to baroreflex stress imposed by Valsalva’s
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Manoeuvre performed during the trimethaphan infusion — where only this subpopulation
persisted to fire (Study One) — or during varying levels of LBNP (Studies Two and
Three). Also, small APs exhibited weak baroreflex slopes during baseline conditions,
then demonstrated paradoxical reductions in baroreflex gain on going from baseline to
LBNP (Study Three). Likewise, Limberg and colleagues (12) observed that the smallest
APs fired with reduced probability (less often) during the hypotensive phase of a
modified Oxford protocol performed in healthy participants. The collective evidence also
suggests that non-nicotinic mechanisms at the paravertebral ganglia primarily initiate the
depolarization of this subpopulation of small APs. Indeed, trimethaphan infusion under
baseline conditions blocked medium and larger AP subpopulations thereby abolishing
integrated bursts of MSNA, but the small APs persisted to fire in an asynchronous
manner (Study One). Upon retrospective analysis of these data focusing on between-burst
AP emissions (Study Two), we identified that small APs firing asynchronously also
survived trimethaphan. Thus, small APs may arise from postganglionic nerves activated
by muscarinic or non-cholinergic receptors, which have been found to contribute to
ganglionic neurotransmission in lower animals (7–9). In addition to weak baroreflex
control centrally, non-nicotinic ganglionic mechanisms may contribute to asynchronous
firing of small APs (3, 4).
In contrast to the medium sized AP clusters, large APs are observed to fire infrequently
during baseline conditions. The present studies highlight new information that this
subpopulation of large APs active under baseline conditions represent a subpopulation of
postganglionic axons regulated primarily by non-baroreflex inputs within the central
sympathetic organization and nicotinic mechanisms at the ganglia. We infer minimal
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baroreflex regulation of this subpopulation based on the finding that under baseline
conditions large APs fired infrequently (Studies One, Two, and Three) and expressed
weak baroreflex slopes (Study Three), then exhibited no change in discharge rate or
baroreflex gain during baroreflex unloading with LBNP (Study Three). However, we
speculate that the central non-baroreflex mechanisms governing larger low-threshold APs
may differ from those regulating the smallest APs as these subpopulations express
incongruent responses in baroreflex gain during LBNP (Study Three). Specifically, while
the smallest APs expressed reductions in baroreflex gain, the large APs demonstrated no
change in baroreflex control from baseline to LBNP (Study Three). Both previously
active APs and the subpopulation of larger latent APs may be regulated by other
peripheral reflexes other than the baroreflex. For example, studies in humans and animals
illustrate that chemoreflex stress preferentially augments burst amplitude, reflecting
higher probability of larger AP discharge (17, 23). The PVN hypothalamus and
periaqueductal gray may also contribute to the regulation of larger APs as animal and
human studies found that activation of these sites (chemical or electrical stimulation) to
increase burst size (18, 24). At the ganglia, the finding that larger APs active under
baseline conditions were de-recruited first by trimethaphan suggests that the
postganglionic axons generating these APs are activated primarily by nicotinic receptors
(Study One). However, we suspect that the patterns of pre-to-postganglionic innervation
vary by sympathetic c-fibre size given the progressive AP blockade (with the exception
of the smallest APs) by trimethaphan from largest to smallest (19, 20).
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5.1

Perspectives

The present studies further our understanding of the sympathetic emissions directed
towards the vasculature supplying skeletal muscle and the mechanisms affecting these
neural patterns. However, this series of studies generated several key questions regarding
the neural processes shaping sympathetic outflow. Specifically, the central networks (i.e.,
supra-spinal and spinal) shaping the behaviour of varying-sized low-threshold APs along
with the recruitment of previously-silent larger APs remain unclear. Techniques
involving simultaneous multi-fibre microneurography and functional magnetic resonance
imaging or stimulation of implanted electrodes may yield new information in this area
(13, 24). For example, by performing microneurography at the same time as functional
imaging in healthy humans, Macefield and colleagues (13, 14) found baseline
sympathetic burst amplitude to relate to the activation of a functional network of nuclei
comprised by the insula, hypothalamus, periaqueductal gray, and RVLM. Consistent with
this finding, stimulation of the dorsolateral periaqueductal gray via implanted deep brain
electrodes produced larger sympathetic bursts compared to pre-stimulation conditions
(24). Although inferences may be drawn regarding the impact of these regions on AP
discharge and/or recruitment, microneurographic studies examining AP behaviour within
these experimental paradigms remain to be conducted. Continued used of
pharmacological agents will also reveal intricacies within the sympathetic organization
(10, 25). For example, pharmacological blockade and activation of the widely centrally
distributed GABA receptors (25) and a2R (26), respectively, have demonstrated
sympathoinhibitory effects, but the influence of the underlying AP patterns remain
concealed by signal integration. Basic studies of this sort are paramount to identifying the
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critical elements of the sympathetic system that contribute to aberrant and overactive
discharge patterns which are hallmark of cardiovascular and neurological pathologies (6,
22).

5.2

Conclusion

The present studies nuanced the complexity of the sympathetic discharge patterns
employed to communicate the appropriate circulatory adjustments for homeostatic
maintenance and the mechanisms subserving these neural behaviours in healthy humans.
Indeed, the arterial baroreflex does not exert strong control over all sympathetic AP
subpopulations and extra-baroreflex processes, both centrally and peripherally, govern
AP discharge. At the paravertebral ganglia, both nicotinic and non-nicotinic mechanisms,
as well as varying degrees of pre-to-postganglionic innervation affect sympathetic AP
discharge. The sympathetic neural architecture produces heterogeneous firing properties
that vary by AP size, such that the distribution of within-burst firing probabilities
resembles an inverted “U” shape under baseline conditions: medium APs fire in most
bursts and the small and large APs discharge infrequently. However, as a result of weak
baroreflex control and non-nicotinic ganglionic neurotransmission, not all AP discharge
occurs synchronously within bursts, as ~30% of total APs fire asynchronously between
bursts of activity at baseline, with the smallest APs expressing the greatest proportion of
asynchronous activity. During baroreflex stress, the sympathetic system increases total
MSNA by increasing the firing probabilities of previously-active low-threshold APs, and
recruiting a subpopulation of larger latent APs. However, not all low-threshold APs
participate in the rate-coding strategy for increasing total MSNA, as only the medium
APs under strong baroreflex control at baseline are reset upwards with operating points
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relocated to positions of enhanced gain to augment firing probability during baroreflex
stress.
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5.3
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